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A B S T R A C T
Background
The high levels of healthcare worker shortage is recognised as a severe impediment to increasing patients’ access to antiretroviral therapy.
This is particularly of concern where the burden of disease is greatest and the access to trained doctors is limited.This review aims to
better inform HIV care programmes that are currently underway, and those planned, by assessing if task-shifting care from doctors to
non-doctors provides both high quality and safe care for all patients requiring antiretroviral treatment.
Objectives
To evaluate the quality of initiation and maintenance of HIV/AIDS care in models that task shift care from doctors to non-doctors.
Search methods
Weconducted a comprehensive search to identify all relevant studies regardless of language or publication status (published, unpublished,
in press, and in progress) from 1 January 1996 to 28 March 2014, with major HIV/AIDS conferences searched 23 May 2014. We had
also contacted relevant organizations and researchers. Key words included MeSH terms and free-text terms relevant to ’task shifting’,
’skill mix’, ’integration of tasks’, ’service delivery’ and ’health services accessibility’.
Selection criteria
We included controlled trials (randomised or non-randomised), controlled-before and after studies, and cohort studies (prospective or
retrospective) comparing doctor-led antiretroviral therapy delivery to delivery that included another cadre of health worker other than
a doctor, for initiating treatment, continuing treatment, or both, in HIV infected patients.
Data collection and analysis
Two authors independently screened titles, abstracts and descriptor terms of the results of the electronic search and applied our eligibility
criteria using a standardized eligibility form to full texts of potentially eligible or uncertain abstracts. Two reviewers independently
extracted data on standardized data extraction forms. Where possible, data were pooled using random effects meta-analysis. We assessed
evidence quality with GRADE methodology.
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Main results
Ten studies met our inclusion criteria, all of which were conducted in Africa. Of these four were randomised controlled trials while the
remaining six were cohort studies.
From the trial data, when nurses initiated and provided follow-up HIV therapy, there was high quality evidence of no difference in
death at one year, unadjusted risk ratio was 0.96 (95% CI 0.82 to 1.12), one trial, cluster adjusted n = 2770. There was moderate
quality evidence of lower rates of losses to follow-up at one year, relative risk of 0.73 (95% CI 0.55 to 0.97). From the cohort data,
there was low quality evidence that there may be an increased risk of death in the task shifting group, relative risk 1.23 (95% CI 1.14 to
1.33, two cohorts, n = 39 160) and very low quality data reporting no difference in patients lost to follow-up between groups, relative
risk 0.30 (95% CI 0.05 to 1.94).
From the trial data, when doctors initiated therapy and nurses provided follow-up, there was moderate quality evidence that there is
probably no difference in death compared with doctor-led care at one year, relative risk of 0.89 (95% CI 0.59 to 1.32), two trials,
cluster adjusted n = 4332. There was moderate quality evidence that there is probably no difference in the numbers of patients lost
to follow-up at one year, relative risk 1.27 (95% CI 0.92 to 1.77), P = 0.15. From the cohort data, there is very low quality data that
death at one year may be lower in the task shifting group, relative risk 0.19 (95% CI 0.05 to 0.78), one cohort, n = 2772, and very low
quality evidence that loss to follow-up was reduced, relative risk 0.34 (95% CI 0.18 to 0.66).
From the trial data, for maintenance therapy delivered in the community there was moderate quality evidence that there is probably
no difference in mortality when doctors deliver care in the hospital or specially trained field workers provide home-based maintenance
care and antiretroviral therapy at one year, relative risk 1.0 (95% CI 0.62 to 1.62), 1 trial, cluster adjusted n = 559. There is moderate
quality evidence from this trial that losses to follow-up are probably no different at one year, relative risk 0.52 (0.12 to 2.3), P = 0.39.
The cohort studies did not report on one year follow-up for these outcomes.
Across the studies that reported on virological and immunological outcomes, there was no clear evidence of difference whether a doctor
or nurse or clinical officer delivered therapy. Three studies report on costs to patients, indicating a reduction in travel costs to treatment
facilities where task shifting was occurring closer to patients homes. There is conflicting evidence regarding the relative cost to the health
system, as implementation of the strategy may increase costs. The two studies reporting the patient and staff perceptions of the quality
of care, report good acceptability of the service by patients, and general acceptance by doctors of the shifting of roles. One trial reported
on the time to initiation of antiretroviral therapy, finding no clear evidence of a difference between groups. The same trial reports on
new diagnosis of tuberculosis which favours nurse initiation of HIV care for increasing the numbers of diagnoses of tuberculosis made.
Authors’ conclusions
Our review found moderate quality evidence that shifting responsibility from doctors to adequately trained and supported nurses or
community health workers for managing HIV patients probably does not decrease the quality of care and, in the case of nurse initiated
care, may decrease the numbers of patients lost to follow-up.
P L A I N L A N G U A G E S U M M A R Y
Shifting HIV care from doctors to non-doctors to improve access to therapy for people living with HIV
Background
High levels of healthcare worker shortage has limited HIV infected patients access to antiretroviral therapy in lower and middle-income
countries. This occurs most where the burden of HIV disease is greatest and where access to trained doctors is limited. We wanted to
assess if task shifting of care from doctors to non-doctors provides both high quality and safe care for all patients requiring antiretroviral
treatment.
Study characteristics
We searched for studies up to March 2014. We found 10 studies, including four randomised controlled trials and 6 cohort studies
collecting data from HIV care programmes. All the studies were conducted in Africa in adults who were followed up for up to one year.
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We describe three types of care:
- Doctor versus nurse or clinical officer care for initiation and maintenance of antiretrovirals
- Doctor versus nurse or clinical officer care for maintenance of antiretroviral therapy
- Doctor versus community health workers for maintenance of antiretroviral therapy.
Key Results.
We found high quality evidence from trial data that when nurses initiated and provided follow-up HIV therapy, there was no difference
in death and lower rates of losses to follow up at one year, (n = 2770). However, lower quality data from two cohort studies suggests
that there may be an increased risk of death in the task shifting group, (n = 39 160) but no difference in patients lost to follow-up
between groups,
We found moderate quality evidence from two trials that when doctors initiated therapy and nurses provided follow-up, that there was
probably no difference in death or number of patients lost to follow up at one year (n = 4332). Lower quality evidence from the cohort
study showed that death as well as the number of patients lost to follow-up at one year may be lower in the group treated by nurses.
Compared to doctor led care, we found moderate quality evidence from a single trial that when antiretroviral therapy was provided in
the community, by trained field workers, there was probably no difference in death or losses to follow-up (n= 559).
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Doctor versus nurse or clinical officer for initiation and maintenance of antiretroviral therapy for HIV-infected patients
Patient or population: HIV-infected patients
Settings: Lower and middle income countries
Intervention: Doctor versus nurse or clinical officer for initiation and maintenance of antiretroviral therapy
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Control Doctor versus nurse or
clinical officer for initia-
tion and maintenance of
antiretroviral therapy
Death (RCTs)
Follow-up: 12 months
194 per 1000 186 per 1000
(159 to 217)
RR 0.96
(0.82 to 1.12)
2770
(1 study)
⊕⊕⊕⊕
high1
Death (Cohorts)
Follow-up: 12 months
92 per 1000 113 per 1000
(105 to 122)
RR 1.23
(1.14 to 1.33)
39160
(2 studies)
⊕⊕©©
low2
Lost to follow-up (RCTs)
Follow-up: 12 months
77 per 1000 56 per 1000
(42 to 75)
RR 0.73
(0.55 to 0.97)
2770
(1 study)
⊕⊕⊕©
moderate3
Lost to follow-up (co-
horts)
Follow-up: 12 months
297 per 1000 89 per 1000
(15 to 577)
RR 0.3
(0.05 to 1.94)
39156
(2 studies)
⊕©©©
very low4
Death or loss to follow-
up (RCTs)
Follow-up: 12 months
271 per 1000 241 per 1000
(214 to 273)
RR 0.89
(0.79 to 1.01)
2770
(1 study)
⊕⊕⊕⊕
high
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Death or loss to follow-
up (Cohorts)
Follow-up: 12 months
389 per 1000 280 per 1000
(187 to 416)
RR 0.72
(0.48 to 1.07)
39160
(2 studies)
⊕©©©
very low5,6
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio;
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1 The confidence interval is narrow and does not include appreciable harm or benefit.
2 Not downgraded for risk of bias. Two retrospective cohorts provided data. Bedelu 2007 included patients with higher CD4 counts at
the health centre. As this is likely to favour the intervention, we did not downgrade for risk of bias.
3 Downgraded by 1 for imprecision. There was a low number of events after adjusting for clustering (<300 events).
4 Downgraded by 1 for imprecision. The confidence interval includes both appreciable harm and appreciable benefit.
5 Downgraded by 1 for imprecision. 95% CI includes appreciable benefit and null value
6Not downgraded for inconsistency. Despite quantitative heterogeneity, both studies showed that attrition was decreased with task
shifting of ART initiation and maintenance to nurses or clinical officers.
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B A C K G R O U N D
Description of the condition
Currently, there are more than 34 million people worldwide in-
fected with HIV, of these, eight million are accessing antiretroviral
therapy (ART) leaving approximately 14 million of those eligible
for ART still in need of treatment ( UNAIDS 2011).Combination
antiretroviral therapy has long been recognised as effective for re-
ducing morbidity and mortality of people infected with HIV and
for maximising their quality of life and longevity (Palella 1998).
The World Health Organization (WHO) supports the roll-out of
antiretroviral therapy to ensure these positive health outcomes and
increasingly treatment is recommended earlier in the course of the
disease, both for the health of those affected and to reduce the risks
of transmission especially in discordant couples, pregnant women
and key populations (WHO 2013; Anglemyer 2013; Cohen 2011
Siegfried 2010). Despite the requirement for increasing access to
HIV therapy, settings with the highest burden of the disease, tend
to have the least access to care (Ford 2011). Shortages of human
resources for health have hampered the scale-up of antiretroviral
therapy in regions most affected by the pandemic.This leaves a
substantial shortfall of people living with HIV/AIDS who cur-
rently or shortly will require antiretroviral treatment. Task shift-
ing of care from doctors to other cadres of health care workers is
proposed to address the inequitable access to antiretroviral therapy
initiation and maintenance (WHO 2008).
Conventionally, most countries applied the doctor-led model in
the management of HIV due to the perceived complexity of the
ARVs and as a policy requirement from donor organisations de-
spite the huge disparity in the doctor : patient ratio in many high
burden settings (WHO 2006). Several studies conducted in high
income settings supported the role of experienced doctors in caring
for patients with HIV (Kitahata 1996; Landon 2005). Although
this may apply in resource rich settings, it does not adequately
address the issues facing poor countries with resource limitations
and the highest burdens of HIV disease. In the settings most af-
fected by HIV, access to HIV treatment needs to be addressed as
a priority, which requires innovative methods to address health
worker shortages (UNAIDS 2011).
The human resource shortage evident in most resource-poor set-
tings is due to a multitude of factors: notable amongst which are
the low rate of recruitment and training of health workers, the
inequitable distribution of health workers (in terms of both the
urban-rural as well as the public-private care disparity) and the
emigration of health professionals from resource-poor to resource-
rich settings (Schneider 2006). A discrete-time model used to es-
timate the human resource requirement necessary to achieve uni-
versal coverage of antiretroviral therapy by 2017, illustrated that
this could only be achieved if the current population of health
workers in sub-Saharan Africa was doubled each year for the next
ten years, with factors such as the emigration of health workers
being kept to a minimum (Barnighausen 2007). While it is im-
perative to increase the rate of recruitment and training of health
workers as well as improve working conditions to reduce attrition
and emigration, the HIV pandemic requires more urgent mea-
sures to address the critical skills shortage. The restructuring of the
health service model from the traditional doctor-led model to one
that allows the shifting of tasks to non-doctors and introduction
of other cadres of health workers has been identified as a way to
solve the skills shortage. By reducing the workload on doctors and
aiming to reduce the cost of health care. Other cadres of health
workers (e.g. nurses, clinical officers or health assistants) may be
engaged in the process of delivering antiretroviral care in a more
sustained way.
How the intervention might work
Task shifting is the process whereby specific tasks are transferred
to different cadres of health workers with shorter training and
fewer qualifications. The definition of the various cadres of non-
physician health workers differs from country to country (Mullan
2007). Task shifting makes efficient use of existing health care
workers in order to ease delays in service delivery (WHO 2008).
Task shifting may also include the delegation of clearly outlined
duties to various levels of healthworkerswho receive specific, skills-
based training. Task shifting aims to provide an equivalent stan-
dard of care to that delivered by higher cadres of health workers.
A Cochrane systematic review (16 studies) appraising nurse-led
versus doctor-led models of general primary health care reported
that 25-75% of activities performed by doctors at the primary
healthcare level could be reallocated to nurses without signifi-
cantly negatively influencing clinical outcomes and quality of care
(Laurant 2004). Similar results regarding quality of care were re-
ported in a South African treatment programme, with a trial that
reported that nurses can provide care that is at least as good as
doctors (Sanne 2010). Substituting nurses for doctors in primary
care did not necessarily result in a reduction in health care costs
when one considers consultation time, requests for further labo-
ratory investigations and prescription practices in addition to the
unit cost of labour (Hollinghurst 2006; Laurant 2004).
In addition to task shifting of antiretroviral initiation and main-
tenance, the model of care may be accompanied by a process of
decentralisation of care, where care is delivered at primary health
care centres or in the community by various cadres of health work-
ers instead of centralised hospital setting at district or higher level
hospitals . In this review we summarise and outline the tiers of
healthcare facilities and the possible health workers found at each
of these levels (Table 1). A Cochrane review on decentralisation of
care evaluated the issue of retention and quality of care in models
to improve access to HIV services, finding that there were lower
losses to follow-up when care was delivered at a health centre,
rather than at a hospital. They also report and that there was prob-
ably no difference both in the attrition and the quality of care
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when antiretrovirals were delivered in the community by trained
community health workers, rather than at the health centre (Kredo
2013).
Why it is important to do this review
A previous narrative review of the literature provides a framework
of the policy, practice and relevant issues being addressed by task
shifting of care, including: efficiency (i.e. time saved where higher
level health workers direct attention to patients with more severe
illness ); access to care (i.e. scaling up those patients able to access
care); quality of care and health outcomes (i.e. mortality, virolog-
ical and immunological responses) and team dynamics (i.e. social
dynamics between cadres of carers anddefinitions of roles, access to
training) (Callaghan 2010). However, the review did not provide
definitive evidence to inform policy and practice, but rather a de-
scription of current programmes. In addition, since it’s publication
several new studies have been published (Assefa 2012; Brennan
2011; Jaffar 2009; Kipp 2010) which report on programmatic
findings of task shifting in lower- and middle-income countries.
A systematic review, Emdin 2013, provided results about the the
quality of care and retention, suggesting that these outcomes were
not worse in task shifted models of care. However, although they
did evaluate risk of bias for the various study designs, they chose
to pool the data from various study designs which may introduce
bias in the reporting of the results.
In some countries with the greatest burden of HIV, task shifting is
already underway - driven by the urgent need to increase numbers
of patients receiving antiretroviral therapy and the dire doctor
: patient ratios in many resource constrained countries (Bedelu
2007; Jaffar 2009). This review aims to better inform theHIV care
programmes that are currently underway, and those planned, on
whether task shifting of care from doctors to non-doctors provides
both high quality and safe care as well as good retention for all
patients requiring antiretroviral treatment.
O B J E C T I V E S
The objective of this review was to evaluate the quality of care
of initiation and maintenance of HIV/AIDS therapy in HIV care
models that task shift care from doctors to non-doctors.
The most clinically important outcome in delivery of ART care is
death, therefore quality of care in the context of this review refers
to death after being considered eligible for treatment, or during
treatment.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised, non-randomised and controlled before and after
studies.
Prospective and retrospective cohort studies with a comparison
between standard delivery of HIV treatment by doctors and one
where components of HIV treatment and care was delegated to a
lower cadre of health carers.
Comparators needed to be health care delivery that was contem-
porary with the new model (delivered at the same time), in the
same country, and geographically adjacent (such as adjacent dis-
tricts within a province).
Types of participants
HIV-infected patients at the point of initiating treatment.
HIV-infected patients on treatment requiring maintenance and
follow-up.
Types of interventions
Intervention
A model of care that involves the initiation or maintenance of
ART by another cadre of health worker other than a doctor [Table
1: Health Service Nomenclature in lower- and middle-income
countries].
Control
Care delivered by a doctor
Types of outcome measures
Primary outcomes
• Quality of care: Death after being considered eligible for
treatment, or during treatment
Secondary outcomes
Clinical
• Loss to follow-up: Any measure of comparative retention
between study populations at set time points after the
intervention as defined by the study authors
• Attrition: composite of death and loss to follow-up
• Time to initiation of ART
• Diagnosis of tuberculosis after entry into HIV care
• Occurrence of a new AIDS defining illness (A newly
diagnosed WHO clinical stage 4 illness)
Laboratory
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• Virologic response to ART (The proportion of participants
that reach or maintain a pre-defined level of viral load
suppression, as defined by the study authors)
• Immunologic response to ART (The mean change in the
concentration of CD4+ lymphocytes from baseline, as expressed
in cells/µL)
Cost
• Cost of care to the provider
• Cost of care to the patient and family
Programme important outcomes
• Patient satisfaction with care (Defined by the study authors
include qualitative analysis if available)
• Any negative impact on other programme and health care
delivery reported by the authors
Search methods for identification of studies
See: Collaboration HIV Review Group search strategy
Electronic searches
In collaboration with the Trial Search coordinator of theCochrane
HIV/AIDS Review Group, we developed a comprehensive search
strategy to identify all relevant studies regardless of language
or publication status (published, unpublished, in press, and in
progress). We searched the following electronic databases from 1
January 1996 (the advent of triple ART) to 16 April 2013:
• MEDLINE (Appendix 1)
• Cochrane Central Register of Controlled Trials
(CENTRAL) (Appendix 2)
• EMBASE (Appendix 3)
• LILACS
• CINAHL
• Web of Science
• Conference on Retroviruses and Opportunistic Infections
Conference
• International AIDS Society Conference
Key words included MeSH terms and free-text terms relevant to
task shifting, skill mix, integration of tasks, service delivery, health
services accessibility and others.
The search was repeated in the key databases including MED-
LINE,CENTRAL,EMBASE and in the registries of ongoing trials
on 28 March 2014. We searched the Conference on Retroviruses
and Opportunistic Infections 2014 and International AIDS Soci-
ety Conference 2013 on 23 May 2014.
Searching other resources
Researchers and relevant organisations. We contacted indi-
vidual researchers working in the field and policymakers based
in inter-governmental organizations including the Joint United
Nations Programme on HIV/AIDS (UNAIDS) and the World
Health Organization (WHO) to identify additional studies either
completed or ongoing.
Reference lists. We checked the reference lists of all studies iden-
tified by the above methods and examined the bibliographies of
any systematic reviews, meta-analyses, or current guidelines which
we identified during the search process.
Ongoing studies. We searched www.clinicaltrials.gov (Appendix
4) and the WHO International Clinical Trials Registry Platform
search portal (Appendix 5) for information on unpublished and
on-going trials.
Data collection and analysis
The methodology for data collection and analysis was based on
the guidance of the Cochrane Handbook of Systematic Reviews
of Interventions (Higgins 2008). Abstracts of all trials identified
by electronic or bibliographic scanning were examined by two
authors working independently. Where necessary, the full text was
obtained to determine the eligibility of studies for inclusion.
Selection of studies
We removed duplicate references using reference management
software. Following this a Cochrane research specialist conducted
a broad review of results, excluding those that were clearly irrele-
vant. Two authors (FBA and TK) independently selected poten-
tially relevant studies by scanning the titles, abstracts, and descrip-
tor terms of the remaining references and applied the inclusion
criteria. Irrelevant reports were discarded, and the full article or ab-
stract obtained for all potentially relevant or uncertain reports. The
two authors independently applied the inclusion criteria. Studies
were reviewed for relevance, based on study design, types of par-
ticipants, exposures and outcomes measures. A neutral third party
adjudicated any disagreements that could not be resolved by dis-
cussion.
Data extraction and management
After initial search and article screening, two reviewers indepen-
dently extracted data and entered information from each selected
study onto standardised data extraction forms.
Extracted information included:
• Study details: citation, start and end dates, location, study
design and details.
• Participant details: study population eligibility (inclusion
and exclusion) criteria, ages, population size, attrition rate,
details of HIV care and disease progression and any clinical,
immunologic or virologic staging, tuberculosis or laboratory
information.
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• Interventions details: any form of health care delivery by
cadres of health workers other than doctors
• Outcome details: mortality, loss to follow-up, time to
initiation of care, diagnosis of tuberculosis, virological outcomes,
immunological outcomes, occurrence of new AIDS defining
illness, patient satisfaction with care, cost of care to patient and
to service provider,other negative impact on service delivery.
The interventions were carefully and systematically described, so
that all of the interventions and co-interventions reported were
captured.
Assessment of risk of bias in included studies
Two review authors independently assessed the risk of bias within
the included studies against key criteria described below. This was
adapted from the methods recommended by the Cochrane Effec-
tive Practice and Organisation of Care Group (EPOC), Newcastle
Ottawa Scale (Newcastle-Ottawa Scale) and The Cochrane Col-
laboration (Higgins 2008). The following judgments were used:
low risk of bias, high risk of bias or unclear risk of bias (either due
to lack of information or uncertainty over the potential for bias).
We resolved disagreements by consensus.
Risk of bias for studies with a separate control group
Randomised controlled trials (RCTs); non-randomised controlled
trials (NRCTs) and controlled before-after (CBA) studies:
Nine standard criteria are suggested for all RCTs,NRCTs andCBA
studies from EPOC. Further information can be obtained from
the Cochrane Handbook section on risk of bias (Higgins 2008A).
We adapted these criteria to best address the included studies and
potential risk of bias presented by them as follows:
1. Adequate generation of the allocation sequence [Trials]
2. Adequate allocation concealment [Trials]
3. Baseline CD4 count measurements were similar [All
studies]
4. Other baseline characteristics were similar [All studies]
5. The study was adequately protected against contamination
[Trials]
6. Data collection methods (i.e. retrospective or prospective)
[Cohorts]
7. The study was free from other risks of bias [we have
specified co-interventions as possibly introducing bias] [All
studies]
8. Patient selection bias [Cohorts]
Assessment of Quality of Evidence Across Studies
We assessed the quality of evidence across a body of evidence (i.e.,
multiple studies with similar interventions and outcomes) with
the
GRADE approach (Guyatt 2011), defining the quality of evidence
for each outcome as “the extent to which one can be confident
that an estimate of effect or association is close to the quantity of
specific interest” (Higgins 2008). The quality rating across stud-
ies has four levels: high, moderate, low or very low. Randomised
controlled trials are categorised as high quality but can be down-
graded; similarly, other types of controlled trials and observational
studies are categorised as low quality but can be upgraded. Factors
that decrease the quality of evidence include limitations in design,
indirectness of evidence, unexplained heterogeneity or inconsis-
tency of results, imprecision of results or high probability of pub-
lication bias. Factors that can increase the quality level of a body of
evidence include a large magnitude of effect, if all plausible con-
founding would lead to an underestimation of effect and if there
is a dose-response gradient.
Measures of treatment effect
We used ReviewManager software (RevMan) provided by the
Cochrane Collaboration for statistical analysis and GRADEpro
software (GRADEpro 2008) to produce GRADE Summary of
Findings tables and GRADE evidence profiles. We summarised
dichotomous outcomes for effect in terms of risk ratio (RR) with
their 95% confidence intervals. We calculated summary statistics
using meta-analytic methods and presented findings in GRADE
Summary of Findings tables and GRADE evidence profiles for the
main outcomes mortality (as an indicator of quality) and loss to
care (an indicator of retention).
Dealing with missing data
Study authors were contacted when missing data was an issue, for
example, we sought additional data from the contact authors for
Assefa 2012; Bedelu 2007, Fairall 2012 and Sanne 2010.
Assessment of heterogeneity
Where clinical or methodological heterogeneity was minimal, we
examined statistical heterogeneity by using the χ2 statistic with a
significance level of 0.10, and the I2 statistic. We interpret an I2
estimate greater than 50% as indicating moderate or high levels
of heterogeneity and investigated its causes where possible (Deeks
2008).
Assessment of reporting biases
There were not sufficient studies available to use a funnel plot to
provide a visual indication of whether reporting bias was present
or not.
Data synthesis
Data were grouped by the level of health care worker providing
care, compared to doctors as outlined in Table 1. When inter-
ventions and study populations were sufficiently similar across the
different studies, we pooled the data across studies and estimated
summary effect sizes using random-effects models. We used the
inverse variance method for analysis of cluster randomised de-
signs.The inverse variance method assumes that the variance for
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each study is inversely proportional to its importance, therefore
more weight is given to studies with less variance than studies with
greater variance.
We summarised the quality of evidence for the main outcomes re-
porting the randomised controlled trial data in GRADE Summary
of Findings tables and GRADE evidence profiles (Guyatt 2011)
Subgroup analysis and investigation of heterogeneity
Data were grouped by the level of health care provider involved as
outlined in Table 1, or additional health care workers as described
in the various studies, degree of task shifting (initiation and main-
tenance of ART or maintenance of ART) and study design (RCT
or cohort studies).
Sensitivity analysis
As the trials included were based on different approaches (supe-
riority vs non-inferiority vs equivalence) we would have liked to
conduct a sensitivity analysis to see if this had any effect on the
result. However, there were too few trials for us to conduct this
analysis. We would also have conducted sensitivity analysis in the
event of significant risk of bias, however, the few trials, were gener-
ally of high quality. Subsequent updates of this review will attempt
to conduct sensitivity analyses where possible.
R E S U L T S
Description of studies
Results of the search
Searches of all mentioned databases were originally conducted in
April 2013, and a repeat search was conducted in Pubmed, Em-
base,TheCochrane Library, ICTRP and clinicaltrials.gov inMarch
2014. We searched the Conference on Retroviruses and Oppor-
tunistic Infections 2014 and International AIDS Society confer-
ence 2013 in May 2014. These search outputs produced 3694
titles after 257 duplicates were removed (Figure 1). TK and FBA
independently selected potentially relevant studies by scanning the
titles, abstracts, and descriptor terms of all downloaded material
from the electronic searches. Irrelevant reports were discarded and
full text articles were obtained for 39 potentially relevant reports.
TK and FBA independently applied the inclusion criteria. Studies
were reviewed for relevance based on: study design, types of par-
ticipants, exposures and outcomes measures. Disagreements were
resolved by discussion. An additional study, suggested through
contact with the technical team at theWorldHealth Organization
was also reviewed. We thus identified four randomised controlled
trials and six cohort studies that met our inclusion criteria for data
extraction, coding and potential meta-analysis. TK, FBA, EP and
MB independently extracted data for the included studies.
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Figure 1. Study flow diagram.
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Included studies
See Characteristics of included studies and a summary of themod-
els of care reported in the included studies in Table 2.
Ten studies, all conducted in adults, are included in this review.
Of these, four are randomised controlled trials (Fairall 2012; Jaffar
2009; Sanne 2010, Kiweewa 2013), two are prospective cohorts
(Humphreys 2010;Kipp2010), while four are retrospective cohort
studies (Assefa 2012; Bedelu 2007; Brennan 2011; Sherr 2010).
One study, was conducted in urban, peri-urban and rural settings
in Ethiopia (Assefa 2012) , two studies were conducted in urban
and rural Uganda (Jaffar 2009;Kipp 2010;), one in urban Uganda
( Kiweewa 2013), one in urban Mozambique (Sherr 2010), one
in rural Swaziland (Humphreys 2010) while the remaining four
studies were conducted in various urban, peri-urban and rural
settings in South Africa (Bedelu 2007; Brennan 2011; Fairall
2012; Sanne 2010). The ten studies contributed a total of 66,606
participants to this review with median baseline CD4 cell count
ranging from 100 to 450 cells/mm3.
Seven studies compared nurse-led care with doctor-led care (Assefa
2012; Bedelu 2007; Brennan 2011; Fairall 2012; Humphreys
2010; Kiweewa 2013; Sanne 2010), one study compared clinical
officer (or non-physician clinician) led care with doctor-led care
(Sherr 2010), while two studies compared care by trained commu-
nity health workers to doctor-led care (Jaffar 2009; Kipp 2010).
In six of the studies, the model of care also involved decentrali-
sation to a more basic level of healthcare facility or to the com-
munity (Assefa 2012; Bedelu 2007; Brennan 2011; Humphreys
2010; Jaffar 2009; Kipp 2010).
There are three main comparisons for this review:
- doctor versus nurse or clinical officer care for initiation andmain-
tenance of antiretrovirals
- doctor versus nurse or clinical officer care for maintenance of
antiretroviral therapy
- doctor versus community health workers for maintenance an-
tiretroviral therapy
Four studies compared doctor-led care versus other cadres for ini-
tiation and subsequent maintenance of patients on ART (Assefa
2012; Bedelu 2007; Fairall 2012; Sherr 2010), while seven studies
evaluated patients who had previously been initiated onARTcom-
paring doctor-led care versus other cadre (Brennan 2011; Fairall
2012; Humphreys 2010; Jaffar 2009; Kipp 2010;Kiweewa 2013;
Sanne 2010), for maintenance of ART. One trial (Fairall 2012)
recruited two patient cohorts: one for initiation and maintenance
and the second for maintenance of ART.
In the included studies, nurses or clinical officers were generally
responsible for the delivery of ART-related tasks including ART
initiation or re-prescription, clinical staging and managing oppor-
tunistic infections. Clinical officers were usually trained for two to
three years (Sherr 2009, Mullan 2007). Detailed descriptions of
these roles are provided in some of the included studies (Bedelu
2007; Sherr 2010). Severe cases and treatment failures were usu-
ally managed by doctors. Community health workers whose ART
specific training ranged from two days (Kipp 2010) to four weeks
(Jaffar 2009) were not responsible for prescribing ART but rather
delivered ART drugs to patients at home, performed adherence
monitoring, monitored clinical symptoms and signs of drug toxi-
city and reported back or referred patients when necessary to the
clinical officer at the facility.
All the studies reported some form of adherence support although
this was more prominently reported in the intervention group
in some studies (Bedelu 2007; Humphreys 2010; Kipp 2010;
Kiweewa 2013). All studies reported access to doctor supportwhen
indicated however, in Bedelu 2007, intervention groups had reg-
ular support visit by a mobile team of experienced doctors.
Excluded studies
See Characteristics of excluded studies
After review of all records found through the search, we evaluated
the full texts of 39 potentially eligible studies. We excluded 29
studies from this review for different reasons. Most of the studies
were excluded based on study design; some were purely descriptive
or cross-sectional study designs and or studies with non-contem-
poraneous comparisons. In one study (Selke 2010), the control
arm had intermittent, poorly quantified, access to a doctor.
Risk of bias in included studies
See Figure 2
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Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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We adapted the EPOC and Newcastle Ottawa risk of bias criteria
to assess the risk of bias in the included studies in order to reflect
the two study designs included in this review: cohort studies and
randomised controlled trials (including cluster randomised con-
trolled trials). See summary of risk of bias by study in Figure 2.
Risk of bias in randomised controlled trials:
Of the four RCTs included in this review, two studies randomised
participants at cluster level (Fairall 2012; Jaffar 2009) while in
the other two studies, randomisation was done at individual level
(Kiweewa 2013;Sanne 2010). All four studies reported comparable
baseline CD4 cell counts (as an indicator of baseline morbidity) in
both intervention and control groups and were rated as low risk of
bias. Three of the studies were balanced on baseline characteristics
such as sex and age andwere rated as having a low risk of bias (Jaffar
2009;Kiweewa 2013; Sanne 2010) , however, Fairall 2012 had a
higher proportion of patients with lower WHO clinical stage in
the intervention group andwas therefore rated as having an unclear
risk of bias. Co-interventions provided to participants or staff were
similar for both intervention and control groups in Jaffar 2009 and
Sanne 2010 andwere thus rated as being at low risk of performance
bias. Furthermore, Fairall 2012 was also rated as being at low risk
of performance bias because the additional training and support
provided to the intervention group was part of the model of care
being tested. Sequence generationwaswell described and adequate
for Fairall 2012, Kiweewa 2013 and Sanne 2010 and hence judged
as having a low risk of bias, however sequence generation was not
described for Jaffar 2009 thus presenting an unclear risk of bias.
Allocation concealment was well described and adequate for all
four RCTsand were rated as being at low risk of bias. Fairall 2012
was judged to be at unclear risk of contamination bias because
additional doctors were assigned to intervention clinics by the
government.No informationwas provided regarding themeasures
to avoid contamination inKiweewa 2013, therefore rated as having
an unclear risk of contamination bias. For the other two studies,
the risk of contamination was low.
Overall the risk of bias was low for Jaffar 2009, Sanne 2010, Fairall
2012, and Kiweewa 2013
Risk of bias in cohort studies
Six cohort studies were included in this review, four of which were
retrospective cohorts and were therefore judged to be at high risk
of bias from the method of data collection. On the indicator of
baseline CD4 cell count, a potential confounder, five studies had
comparable CD4 cell counts in both intervention and control
groups and were judged to be at low risk of bias, except for Bedelu
2007 which was assessed to be at high risk of bias on account
of higher CD4 cell counts in intervention group. In two studies,
(Brennan 2011; Sherr 2010) both intervention and control groups
were similar for the indicator evaluating other baseline characteris-
tics (which included age, sex,WHOclinical stage, amongst others)
and were thus assessed as being at low risk of bias. The other four
studies did not present adequate data to assess this domain and
therefore had an unclear risk of bias for this indicator. As regards
co-interventions, apart from Brennan 2011 and Humphreys 2010
which were rated as being at low risk of bias, all other studies had
a high or unclear risk of performance bias. In Bedelu 2007, the
intervention group received regular support visits by experienced
clinicians, while Kipp 2010 required a treatment supporter in the
intervention group to support adherence. In Sherr 2010, both
groups saw multiple care providers during the period of analysis -
these three studies were rated as being at high risk for performance
bias. Information presented by Assefa 2012 was inadequate and
was thus judged to have an unclear risk of performance bias. Ex-
cept for Sherr 2010 which was rated as having an unclear risk of
selection bias because assignment to initial provider was said to be
at “clinic discretion”, we did not identify other additional risks of
bias in patient selection for the other five studies and thus judged
this indicator as low risk.
Effects of interventions
See: Summary of findings for the main comparison Doctor
versus nurse or clinical officer for initiation and maintenance of
antiretroviral therapy for HIV-infected patients; Summary of
findings 2Doctor versus nurse or clinical officer for maintenance
of antiretroviral therapy forHIV infected patients on antiretroviral
therapy; Summary of findings 3Doctor versus community health
worker for maintenance of antiretroviral therapy for HIV infected
patients on antiretroviral therapy.
Nurses or clinical officers versus doctors for initiation and
maintenance of antiretroviral therapy
See Summary of findings for the main comparison
Four studies, including one randomised controlled trial (Fairall
2012) and three retrospective cohorts (Assefa 2012; Bedelu 2007;
Sherr 2010) examined this comparison.Datawas groupedby study
design. Sherr 2010 was not included in the data analysis as there
was substantial contamination and patients could choose whether
they saw a doctor or clinical officer at their follow-up visits.
1. Death (12 months)
Overall there is high quality evidence of no difference in mortal-
ity whether nurses or doctors initiate antiretroviral therapy. This
is true provided that the model of care includes specific training
andorganisational support for professional nurse practitioners pre-
scribing and following up antiretroviral therapy for newly initiated
patients. Data from two retrospective cohorts with methodologi-
cal limitations due to selection bias provided low quality evidence,
however they were not downgraded further as the direction of the
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bias was likely to favour the intervention (Analysis 1.1, Figure 3).
Figure 3. Forest plot of comparison: 1 Doctor versus nurse or clinical officer (initiation and Maintenance of
ART) , outcome: 1.1 Death (12 months).
Evidence from clinical trials
One cluster randomised trial (Fairall 2012), conducted in 31 peri-
urban and rural clinics in South Africa, enrolled patients between
January 2008 and June 2009. The specific group (cohort 1) within
this trial included patients whowere eligible for ART or were likely
to become eligible during the trial. A total of 9252 patients were
enrolled, however, adjusting for the design effect introduced by
the clustering, an effective sample size of 2,770 adults provided
data for this outcome. Participant characteristics were similar at
baseline (sex, age, CD4 cell count), except there were moreWHO
clinical stage I (52% vs. 32%) and fewer WHO clinical stage III
(24% vs. 38%) patients in the intervention group. The trial had
methodological limitations due to unclear risk of contamination
from additional doctors being drafted to intervention clinics by
the provincial department of health. In addition, 965/3712 (26%)
patients were initiated on therapy by a nurse in the intervention
group compared to none in the control group. The results reported
no difference in mortality between nurse-led and doctor-led ini-
tiation of ART and maintenance care with the adjusted HR 0.92
(95% CI 0.76 to 1.12), P = 0.4, adjusted for age, sex, CD4 cell
count and available identify number. The unadjusted risk ratio
was 0.96 (95% CI 0.82 to 1.12), P = 0.57 (Analysis 1.1). Overall
there is high quality evidence from the clinical trial that there is
no difference in mortality outcomes between those patients initi-
ated and followed up by nurses compared to those initiated and
followed up by doctors.
Evidence from observational studies
Three retrospective cohort studies examined this outcome (Assefa
2012; Bedelu 2007; Sherr 2010), but only the first two including
39,160 adults contributed data for this analysis. For the two in-
cluded cohorts, in addition to the inherent bias and confounding
associated with cohort studies, Bedelu 2007, set in rural South
Africa, included patients with higher CD4 cell counts in the in-
tervention group presenting a high risk of selection bias, further-
more, the intervention group also received regular support from
experienced clinical staff with resultant further risk of performance
bias. On the other hand, although Assefa 2012 , set in rural and
peri-urban Ethiopia, had similar baseline CD4 cell counts in both
groups, other characteristics such as sex, age and clinical stage at
baseline were not described. Analysis of mortality at 12 months
reported an increased risk of death in the task shifting group; the
RRwas 1.23 (95%CI 1.14 to 1.33) with no statistical heterogene-
ity detected. There was low quality evidence of a 23% increased
risk of death in the task shifting group in spite of the fact that the
baseline imbalance in morbidity should bias the result in favour
of task shifting.
The use of crude proportions extracted from the study reports
does not adjust for important potential confounding or take into
account the losses of patients over time. The quality of the data was
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not further downgraded for risk of bias, as the direction of the bias
was expected to favour the intervention and yet the control was
favoured in the results. This cohort provided low quality evidence
that there may be an increased risk of death in models of care that
include both decentralisation and task shifting.
2. Loss to follow-up (12 months)
We extracted data on patients lost to follow-up, as it is more con-
sistently reported and defined across studies, as a surrogate for
the outcome retention. Overall there is moderate quality evidence
fromone cluster randomised trial that supports lower lossto follow-
up when nurses initiated andmaintained patients on antiretroviral
therapy, compared to doctors. The quality of the data was down-
graded for imprecision due to the relatively low number of events.
The trial describes specific methods to support nurse practitioners
to initiate treatment and also ensures adequate adherence support
for patients (Analysis 1.2, Figure 4)
Evidence from clinical trials
The Fairall 2012 trial including a cohort of patients eligible to
initiate antiretroviral therapy is described in detail above. Losses
to follow-up were defined as patients not having reported to the
clinic in previous three months and whose vital status was not
known at the end of the trial. The trial reported a slightly lower rate
of loss to follow-up in the task shifting group (5.5%) compared
with the doctor group (7.7%) with a RR of 0.73 (95% CI 0.55 to
0.97), P = 0.03 (Analysis 1.2). In this trial, retention was defined
as patients who are alive and still enrolled in the programme after
12 months, were not known to have withdrawn or relocated, and
had a documented clinic visit or laboratory test in the previous
six months if started on ART or last known CD4 cell count was
below 200 cells/mm3 or in the past nine months if they had not
yet started ART and had a CD4 cell count > 200 cells/mm3. The
adjusted risk ratio for participant retention in this trial was 1.10
(95% CI 1.04 to 1.16), P = 0.001, adjusted for randomisation
strata and intra-cluster correlation of outcomes.
Evidence from observational studies
Figure 4. Forest plot of comparison: 1 Doctor versus nurse or clinical officer (initiation and Maintenance of
ART) , outcome: 1.2 Lost to follow-up (12 months).
Two retrospective cohort studies, Bedelu 2007 and Assefa 2012,
contributed data for this outcome. There were no adjusted results
available and as such the crude data is reported. There was no
difference in patients lost to follow-up between the task shifting
group and doctor-led care, the relative risk was 0.30 (95%CI 0.05
to 1.94), P = 0.21 (Analysis 1.2). There was substantial statisti-
cal heterogeneity between the studies (I2= 98%). In addition, we
found potential clinical heterogeneity in patients’ baseline charac-
teristics (e.g. CD4 cell counts), and methodological heterogeneity
of the models of care provided. Although both studies are consis-
tent in favouring lower numbers of patients lost to follow-up in
16Task shifting from doctors to non-doctors for initiation and maintenance of antiretroviral therapy (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
the intervention groups, due to imprecision indicated by the wide
confidence interval, we have downgraded the quality of the data.
These data provide very low quality evidence that there may be no
difference in the patients lost to follow-up.
3. Attrition (death or lost to follow-up at 12 months):
Evidence from trials
Analysis of the composite outcome of attrition from the single
trial above shows that there is high quality evidence that overall
attrition is similar in both task-shifted and doctor-led initiation
and maintenance of antiretroviral therapy, at 12 months follow
up, RR = 0.89 (95% CI 0.0.79 to 1.01), P = 0.08 (Analysis 1.3).
Evidence from observational studies
Overall, there is very low quality evidence that attrition in patients
task shifted to nurses or clinical officers compared with doctor-led
initiation and maintenance of care were similar, RR = 0.72 (95%
CI 0.48 to 1.07), P = 0.11. Despite quantitative heterogeneity,
both studies consistently showed that attrition was decreased with
decentralisation and task shifting. The effect sizes varied however,
with Assefa 2012 showing more modest effects, 3%, while Bedelu
2007 reports a 42% decrease. The quality of the evidence was
downgraded due to imprecision.
Nurses or clinical officers versus doctors for maintenance of
antiretroviral therapy
See Summary of findings 2
Three studies including two randomised controlled trials (Fairall
2012; Sanne 2010) and one retrospective cohort study (Brennan
2011) examined this comparison. Data was grouped by study de-
sign and describes the two critical outcomes, death and those pa-
tients lost to care.
1. Death (12months)
Overall, there is moderate quality evidence that there is probably
no difference in death whether antiretroviral maintenance care is
delivered by a nurse or by a doctor. The data was downgraded for
imprecision due to a wide confidence interval and relatively low
event rate. (Analysis 2.1, Figure 5)
Evidence from trials
Two trials contributed data to this analysis (Fairall 2012; Sanne
2010). Both trials took place in rural or peri-urban settings in
South Africa, shifting care to nurses.. Both had a low risk of bias
for all the parameters in our modified criteria for risk of bias, ex-
cept that Fairall 2012 had an unclear risk of contamination from
doctors being drafted to intervention sites by the provincial gov-
ernment. Fairall 2012 recruited a different cohort (cohort 2 in
the trial) from that described above, as patients were already on
antiretroviral therapy and were then referred to care by a nurse,
rather than the standard care which included a doctor. The pro-
fessional nurses received a specific package of training to enable
them to monitor clinical and drug effects for these patients and
received specific support through supervision and involvement of
clinic management in the model of care. In the Sanne 2010 trial,
primary care nurses and doctors, not experienced with ART de-
livery were provided with specific didactic and clinical training in
line with National guidelines. Contamination was prevented in
this trial by scheduling patients for the respective cadre of health
workers on different days. The trial aimed to provide continu-
ity of care, and patients were able to see the same practitioner at
each follow up visit. Additional adherence support was provided
by lay counsellors. Prior to meta-analysis, data from the cluster
randomised trial Fairall 2012, was adjusted for the design effect
using the intra-cluster correlation coefficient reported in the study
before being combined in a meta-analysis. The result showed no
difference in mortality between task shifting and doctor-led ART
maintenance care when ART had previously been initiated by a
doctor, with a RR of 0.89 (95% CI 0.59 to 1.32), P= 0.55. There
was no statistical heterogeneity (I2= 0%).
Evidence from observational studies
There is very low quality data from one retrospective cohort study
(Brennan 2011) that mortality may be lower in the nurse-led care
arm, The study used propensity scoring to match patients in in-
tervention and control groups. In this study, task shifting also
involved decentralization from hospital to health centre care. In
addition to the propensity scoring, Brennan 2011 reported ad-
justed rates of mortality at 12 months, adjusted hazard ratio was
0.2 (95% CI 0.04 to 0.8)/ 100 person years. This was adjusted
for baseline characteristics including sex, age, CD4+ cell count.
The crude result from the proportions data we extracted provides
similar results, a statistically significantly reduced risk of death in
task shifting group compared to doctor-led care; RR of 0.19 (95%
CI 0.05 to 0.78), P = 0.02.
2. Loss to follow-up (12 months)
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Figure 5. Forest plot of comparison: 2 Doctor versus nurse or clinical officer (Maintenance of ART),
outcome: 2.1 Death (12 months).
Overall there is moderate quality evidence from two trials that
there is probably no difference in the numbers of patients lost
to follow-up whether nurses or doctors provide follow up and
maintenance antiretroviral care after 1 year of follow up.(Analysis
2.2, Figure 6)
Evidence from clinical trials
Analysis of data from the two RCTs which reported on death also
showed no difference in the numbers of patients lost to care in
task shifted care compared to doctor-led care with a relative risk
of 1.27 (95% CI 0.92 to 1.77), P = 0.15. There was no statistical
heterogeneity between the results of studies included in this anal-
ysis. The quality of the data was downgraded for imprecision, and
we therefore report moderate quality data that there is probably
no difference in patients lost to care whether doctors or nurses
provide HIV care at similar primary care health centres.
Evidence from observational studies
The single cohort (Brennan 2011), showed significantly less loss to
follow-up in the task shifting group compared to doctor led ART
maintenance care. There was a relative risk reduction of 66% - RR
= 0.34 (95% CI 0.18 to 0.66), P = 0.001. This data is considered
very low quality due to the nature of the study design and the
imprecision of the results with the low event rates reported.
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Figure 6. Forest plot of comparison: 2 Doctor versus nurse or clinical officer (Maintenance of ART),
outcome: 2.2 Lost to follow-up (12 months).
3. Attrition (death or lost to follow-up at 12 months):
Evidence from clinical trials
Analysis of data on this composite outcome of death or loss to fol-
low-up from the twoRCTs (Fairall 2012; Sanne 2010) also showed
no difference in overall attrition in task shifted care compared to
doctor-led care with a relative risk of 1.1 (95% CI 0.86 to 1.41), P
= 0.46. There was no statistical heterogeneity between the results
of studies included in this analysis. The quality of the data was
downgraded for imprecision , and we therefore report moderate
quality evidence that there is probably little or no difference in
overall patient attrition whether doctors or nurses provide HIV
maintenance care at similar primary care health centres.
Evidence from observational studies
The single cohort (Brennan 2011), showed that overall patient
attrition was significantly less in the task shifting group compared
to doctor led ART maintenance care. There was a relative risk
reduction of 70% - RR = 0.3 (95% CI 0.17 to 0.54), P < 0.0001.
This data is considered very low quality due to the imprecision
of the results with the low event rates reported and should be
cautiously interpreted on account of the bias and confounding
inherent in the observational study design.
Doctor versus community health worker for maintenance of
antiretroviral treatment
See Summary of findings 3
One randomised controlled cluster trial (Jaffar 2009) contributed
data for the critical outcomes death and patients lost to follow-up
at 12 months.
1. Death (12 months)
This analysis provides moderate quality evidence that there is
probably no difference in mortality when doctors deliver care in
the hospital or specially trained field workers provide home-based
maintenance care and ART delivery. The quality of the data was
downgraded for imprecision due to the small effective sample size
and event rate, resulting in a wide confidence interval. (Analysis
3.1, Figure 7).
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Figure 7. Forest plot of comparison: 3 Doctor versus community health worker, outcome: 3.1 Death (12
months).
Evidence from clinical trial
One trial investigated task shifting from doctor to specifically
trained community worker for ART maintenance care (Jaffar
2009). This trial took place in various parts of urban, peri-urban
and rural Uganda and included adults patients, who were initiated
on treatment in hospital by doctors, and then down referred only
once stable on their treatment and consented to down referral. The
intervention group received home based community worker sup-
port and monitoring with a field officer monthly using a checklist
and mobile phone, with daily review of the field officers notes by
the designated medical officer. The patients were still seen at the
hospital six monthly (Jaffar 2009). Overall, this trial had a low risk
of poor internal validity (Figure 2), however it was underpowered
(small sample sizes and event rates) to address the question. The
adjusted rate ratio for mortality was 0.95 (95% CI 0.71 to 1.28)/
100 person years, adjusted for study stratum and CD4 cell count
category. In order to adjust for the design effect, we required an
intra-cluster co-efficient (ICC). As this was not provided for this
trial, we made a statistical assumption and used a liberal ICC of
0.05. After adjusting for clustering with an assumed intra-cluster
coefficient of 0.5, the effective sample size was 559, and the cal-
culated risk ratio is 1.0 (95% CI 0.62 to 1.62).
Evidence from observational studies
None provided 12 month data. Kipp 2010 provided data for 6
months of followup, shown in the data and analysis table (Analysis
3.1). This cohort evidence was not included in the summary of
finding tables for 12 month follow up.
2. Loss to follow-up (12 months)
There is moderate quality evidence from this trial that loss to fol-
low-up is probably not different whether doctor or home-based
care is provided in this manner. The quality of the data was down-
graded for the small sample size, low number of events and wide
confidence interval.
Evidence from clinical trial
The Jaffar 2009 trial also reported on this outcome. No adjusted
result was found in the published report, however, we adjusted
for clustering (using the liberal ICC of 0.05). The relative risk for
patients lost to follow-up was 0.52 (0.12 to 2.3), P = 0.39. There
is moderate quality evidence from this trial that losses to follow-
up are probably no different whether doctor or home-based care
is provided in this decentralised manner. The quality of the data
was downgraded for the small sample size, low number of events
and wide confidence interval.(Analysis 3.2, Figure 8)
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Figure 8. Forest plot of comparison: 3 Doctor versus community health worker, outcome: 3.2 Lost to
follow-up (12 months).
Evidence from observational studies
None provided 12 month data. Kipp 2010 provided data for 6
months of followup, shown in the data and analysis table (Analysis
3.2). This cohort evidence was not included in the summary of
finding tables for 12 month follow up.
3. Attrition (death or lost to follow-up at 12 months):
Evidence from clinical trials
Similarly the single RCT providing data for this composite out-
come shows similar overall attrition for doctor-led as well as com-
munity officer-led (home based) maintenance care of HIV. The
relative risk for attrition was 0.93 (0.6 to 1.46), P = 0.76, this evi-
dence was of moderate quality as we downgraded for imprecision.
Evidence from observational studies
None provided 12 month data. Kipp 2010 provided data for 6
months of followup, shown in the data and analysis table (Analysis
3.3). This cohort evidence was not included in the summary of
finding tables for 12 month follow up.
Other outcomes
Immunological changes - CD4+ count
Seven of the ten included studies report on CD4 cell count. As
they all report the CD4 cell count variably with some reporting
means and others medians, this data was not pooled.
For initiation and maintenance, Fairall 2012 (cohort 1) reports
a CD4 cell count mean (SD) at follow up by nurses 161 cells/
mm3 (175) compared to doctor 141 cells/ mm3 (161), with the
difference in the means of 22.3 cells/ mm3 (3.6 to 40.9), P =
0.02, favouring nurse led care. This was adjusted for randomisa-
tion strata and intra-cluster correlation. Bedelu 2007 reports the
proportion of patients with a CD4 cell count above 200 cells/m
3. The crude proportion indicated that 303/348 tests done in the
health centre under nurse care were above this threshold compared
to 61/81 of those conducted at the hospital by doctors. Assefa
2012 does not report on this outcome.
For maintenance of care, Fairall 2012 (cohort 2) reports that the
mean (standard deviation) for CD4 cell count at follow up by
nurses was 438 (SD 219) compared to doctors 418 (SD201), with
the difference in themeans reported as 24.2 (7.2 to 41.3), P =0.007
favouring nurse care. This was adjusted for randomisation strata
and intra-cluster correlation. Sanne 2010 reported the median
increase inCD4 cell count. At 1 year, patients in nurse-led care had
a median increase of 155 cells/mm3 (IQR 119 to 193) compared
to doctor -led care with a median increase of 158 cells/mm3 (IQR
125 to 169). This was sustained to 2 years, where patients being
cared for by nurses has a median increase of 239 cells/mm3 (IQR
217 to 290) compared to doctor-led care of 220 cells/mm3 (IQR
174 to 274). These results are not clinically significantly different.
Humphreys 2010 reports mean change at six months only, where
patients in nurse care have a CD4 cell count of 103 cells/mm3
compared to those in doctor care with a mean change of 103 cells/
mm3 (P = 0.7). Kiweewa 2013 reports similar mean increases in
CD4 count between groups around 200 cells/mm3 after 6 to 12
months. Brennan 2011 did not report on this outcome.
For the comparison of community field worker follow up com-
pared to doctor care, the 12 month median (IQR) is reported,
where patients in the community had a CD4 cell count of 250
cells/ mm3 (IQR 180 to 350) compared to 260 cells/mm3 (IQR
190 to 375) which was not statistically significant.
Viral load suppression
Five of the included studies report variably on this outcome.
Bedelu 2007 and Kiweewa 2013 reported on the proportion of
patients with viral loads below 400 copies/mL. The nurses group
in Bedelu 2007 was 89.5% below this threshold compared to
78% in the doctors group, but of note, there was a substantial
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difference in the numbers of viral load tests conducted between
the groups, 50% compared to 10% of patients tested in the nurse
and doctor group respectively. In Kiweewa 2013 the proportion
with a viral load <400 copies/mL at 6 to 12 months was similar
between groups.
Fairall 2012 found no difference in either cohort for virological
suppression. The trial reports an adjusted risk ratio for those pa-
tients with a viral load below 400 copies/mL in cohort 1 (initiation
and maintenance) with an adjusted RR of 0.97 (95% CI 0.9 to
1.03), P = 0.324. In cohort 2 (maintenance of care), the risk dif-
ference of those with suppressed viral load is reported as RD 1.1%
(-2.3 to 4.6), P = 0.534. Sanne 2010 reports the hazard ratio for
all virological failure (including early failure which is less than 1.5
log decrease in viral load from baseline to 12 weeks of treatment;
and late virological failure which is two consecutive viral load four
weeks apart of more than 1000 copies/mL. The hazard ratio was
1.15 (95% CI 0.75 to 1.76) indicating no statistical difference
between the groups.
Jaffar 2009 was the only study reporting this outcome for the com-
parison of community field officer care with doctor care. They
reported an adjusted rate ratio for having a viral load above 500
copies/mL of 1.04 (95% CI 0.78 to 1.4), thus, there was no dif-
ference between the groups.
Overall, the reported virological suppression or failure rates were
similar between the intervention and control groups, except in
Bedelu 2007 which had a relative imbalance in the numbers of
patients being tested for viral loads between groups and being a
retrospective cohort, may not have been adequately powered for
this outcome.
Cost to providers and patients
One prospective cohort, Humphreys 2010, reports specifically on
the cost of travel for patients. The average cost for a patient seen
by a nurse was USD 0.74 compared to USD 1.5 for a patient seen
at the hospital by a doctor (P = 0.001) (Analysis 1.4).
Two studies provided data for the outcome on overall cost to pa-
tients. Both reports come from community based treatment by a
field worker compared to standard doctor-led hospital based treat-
ment (Jaffar 2009; Kipp 2010). Both studies indicate substantial
increases in the cost to patients when they are required to travel
to the hospital, which is usually further from their homes. Kipp
2010 reports a doubling of cost to patients when accounting for
transport only. Jaffar 2009, in the cluster trial, reports a three times
increase in costs, including transport, lost work time, child-care
costs and food (Analysis 3.4).
Costs to the health service are also reported. Jaffar 2009 reported
costs to health service for community care versus doctor-led hos-
pital based groups. These costs included staff, transport, drugs,
laboratory, training, supervision, capital and utilities costs and was
a mean of USD 793 / year for each patient in the home based
group compared to USD 838 / year / patient in the hospital based
group.
A sub-study of the Fairall 2012 included an evaluation of cost-
effectiveness of the interventions related to doctor- versus nurse-
led care. In particular, the study evaluated the incremental cost
effectiveness ratio (ICER). They concluded that nurse-led care
(including training, supervision, and treatment for TB and HIV)
was associated with higher mean health service costs compared to
doctor led care without substantial effects on the health outcomes
of patients.
Time to initiation of ART,
For initiation and maintenance Fairall 2012 (cohort 1) reported
the adjusted hazard ratio for time to initiation of ART as 1.14
(95% CI 0.92 to 1.43), P = 0.232, adjusted for randomisation
strata and intra-cluster correlation of outcomes.
New tuberculosis diagnosis
For initiation and maintenance, Fairall 2012 (cohort 1) reports
on new tuberculosis diagnoses being made, the risk ratio was 1.46
(95%CI 1.18 to 1.81), P = 0.001, supporting superiority of nurses
compared to doctors in this model of care for diagnosing tubercu-
losis. For maintenance of care Fairall 2012 (cohort 2) report the
risk difference between groups for new tuberculosis diagnosis of
0.21% (95% CI -2.1 to 1.54), P = 0.758, indicating equivalence
of the diagnosis rate regardless of whether a doctor or nurses de-
livered the care.
Patient satisfaction with care
Assefa 2012 and Humphreys 2010 included a qualitative compo-
nent to their studies which reports on patient satisfaction with the
model of care by group.
Assefa 2012 evaluated patient satisfaction with care by conduct-
ing two hour long focused group discussions (57 patients, in 7
groups). They looked predominantly at the issue of task shifting
and its acceptability amongst patients and healthcare providers.
Patients reported that nurse and health officer (clinical officer)
services were ’generally well accepted, and reduced waiting time’,
they also revealed that they were ’more comfortable with nurses
than with physicians because nurses were friendlier and more sup-
portive’. Patients emphasised that nurses and health officers spent
more time with them discussing their medical problems and took
enough time examining them. Patients, who assisted with care
provision, identified three additional benefits of being involved in
ART delivery: their life experience helped them to provide appro-
priate counselling; it helped combat stigma and discrimination in
society; and it provided them with an opportunity for employ-
ment. In the same study, focused group discussions were held with
programme managers and health care providers who agreed that
the model including task shifting provided a timely solution for
Ethiopias needs. They also agreed that nurses and health officers
can provide high quality care given adequate training and super-
vision.
Humphreys 2010 was a prospective cohort that used the model of
task shifting from doctors to nurses and decentralisation from hos-
pital to health centre. This study included a qualitative assessment
of patient satisfaction as a primary outcome. Those attending the
intervention clinic were asked about their level of satisfaction, 25/
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31 of those who responded said that they were very satisfied with
the care received. Reasons provided included the reduced cost of
transport, being nearer to home, shorter queue, being treated bet-
ter by staff, receiving better care and that they would not be talked
about. The two respondents who were not satisfied with the care
complained about the lack of a doctor, saying they did not have
money to get to themain clinic, and that there was a delay because
staff from the hospital arrived late at the health centre.
Time to initiation of antiretroviral therapy
Fairall 2012 (cohort 1) reports on initiation and maintenance,
and includes time to initiation of ART as one of the secondary
outcomes. The reported hazard ratio is 1.14 (0.92 to 1.43), P =
0.2, comparing nurses to doctor-led care. This was adjusted for
the competing risk, death.
New AIDS defining illness, any negative impact on the health
delivery
None of the included studies specifically reported on new AIDS
defining illness or on general negative impacts on health delivery.
23Task shifting from doctors to non-doctors for initiation and maintenance of antiretroviral therapy (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Doctor versus nurse or clinical officer for maintenance of antiretroviral therapy for HIV infected patients on antiretroviral therapy
Patient or population: HIV infected patients on antiretroviral therapy
Settings: Lower and middle-income countries
Intervention: Doctor versus nurse or clinical officer for maintenance of antiretroviral therapy
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Control Doctor versus nurse or
clinical officer for main-
tenance of antiretroviral
therapy
Death (RCTs)
Follow-up: 12 months
23 per 1000 20 per 1000
(14 to 30)
RR 0.89
(0.59 to 1.32)
4332
(2 studies)
⊕⊕⊕©
moderate1
Death (Cohorts)
Follow-up: 12 months
15 per 1000 3 per 1000
(1 to 12)
RR 0.19
(0.05 to 0.78)
2772
(1 study)
⊕©©©
very low2
Lost to follow-up (RCTs)
Follow-up: 12 months
28 per 1000 36 per 1000
(26 to 49)
RR 1.27
(0.92 to 1.77)
4332
(2 studies)
⊕⊕⊕©
moderate3
Lost to follow-up (Co-
horts)
Follow-up: 12 months
42 per 1000 14 per 1000
(8 to 28)
RR 0.34
(0.18 to 0.66)
2772
(1 study)
⊕©©©
very low2
Death or loss to follow-
up (RCTs)
Follow-up: 12 months
51 per 1000 56 per 1000
(44 to 72)
RR 1.1
(0.86 to 1.41)
4332
(2 studies)
⊕⊕⊕©
moderate3
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Death or loss to follow-
up (Cohorts)
Follow-up: 12 months
57 per 1000 17 per 1000
(10 to 31)
RR 0.3
(0.17 to 0.54)
2772
(1 study)
⊕©©©
very low2
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio;
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1 Downgraded by 1 for imprecision. There was a low number of events (<300) and the 95% confidence interval includes appreciable
harm and benefit.
2 Downgraded by 1 for imprecision, due to low event numbers (<300).
3 Downgraded by 1 for imprecision. There was a low number of events (<300) after adjusting for clustering in the Fairall 2012 study.
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Doctor versus community health worker for maintenance of antiretroviral therapy for HIV infected patients on antiretroviral therapy.
Patient or population: HIV infected patients on antiretroviral therapy.
Settings: Lower and middle-income countries
Intervention: Doctor versus community health worker for maintenance of antiretroviral therapy
Outcomes2 Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Control Doctor versus com-
munity health worker
for maintenance of an-
tiretroviral therapy
Death (RCTs)
Follow-up: 12 months
109 per 1000 109 per 1000
(68 to 177)
RR 1
(0.62 to 1.62)
559
(1 study)
⊕⊕⊕©
moderate1
Lost to follow-up (RCTs)
Follow-up: 12 months
17 per 1000 9 per 1000
(2 to 40)
RR 0.52
(0.12 to 2.3)
559
(1 study)
⊕⊕⊕©
moderate1
Death or lost to follow-
up (RCTs)
Follow-up: 12 months
127 per 1000 118 per 1000
(76 to 185)
RR 0.93
(0.6 to 1.46)
559(1 study) ⊕⊕⊕©
moderate1
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio;
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
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1 Downgraded by 1 for imprecision.This cluster randomised trial was adjusted for design effect having assumed an intra-cluster
correlation coefficient (0.05) as none was provided in the report. The resultant 95% confidence interval included appreciable benefit
and harm.
2 No cohorts were reported for this comparison
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
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D I S C U S S I O N
Summary of main results
This review found high quality evidence that there is no difference
in the mortality whether nurses or doctors initiate antiretroviral
therapy provided that the model of care includes specific train-
ing and organisational support for professional nurse practition-
ers prescribing and following up antiretroviral therapy for newly
initiated patients. Overall there is moderate quality evidence from
one cluster trial that supports lower loss to follow-up when nurses
initiated and maintained patients on antiretroviral therapy, com-
pared to doctors. The quality of the data was downgraded for im-
precision due to the relatively low number of events. Cohort data
with methodological limitations and low precision conflicted with
the trial evidence, as we found low quality evidence of increased
deaths in the task shifted group, and very low quality evidence of
no difference in patients lost to follow-up.
We foundmoderate quality evidence that task shifting of antiretro-
viral maintenance care from doctors to nurses probably results in
no difference in death at one year.Overall there ismoderate quality
evidence from two trials that there is probably no difference in the
numbers of patients lost to follow-up whether nurses or doctors
provide maintenance antiretroviral therapy at one year. The data
was downgraded for imprecision due to a wide confidence inter-
val and relatively low event rate. Cohort data conflicted with the
evidence from the trials and reported very low quality evidence of
lower deaths and losses to follow up at one year.
We found moderate quality evidence that there is probably no
difference in the mortality when doctors deliver care in the hospi-
tal or specially trained field workers provide home-based mainte-
nance care and ARTdelivery in the community. There is moderate
quality evidence from this trial that loss to follow-up is probably
no different whether a doctor or a field worker deliver care in this
decentralised manner. The quality of the data was downgraded for
imprecision due to the small effective sample size and event rate,
resulting in a wide confidence interval. There was no data from
the cohorts for these outcomes at one year.
With respect to other relevant outcomes, the cohorts reporting
CD4 cell counts showed increases in immunological status, with
no difference between models of care. Similar results were found
for changes in viral load, a marker of the effectiveness of antiretro-
viral therapy, with studies reporting comparable virological sup-
pression regardless of the model of care employed.
Costs, reported by three studies are considerably reduced for both
the patient and provider, when issues of travel and staffing are con-
sidered. However, when the cost of implementing the intervention
are considered, including training and supervision, the costs for
task shifted care may be increased for the health system.
There was a high level of acceptability to patients reported by the
two studies in which this was assessed when therapy is delivered
by nurses rather than doctors.
Overall completeness and applicability of
evidence
The clinical trials that are included in this review providemoderate
quality evidence that substitution of nurses or community workers
to initiate and maintain ART for people receiving HIV services
in rural and peri-urban settings in South Africa and Uganda is
feasible and are likely to be representative of lower- and middle-
income countries.
Task shifting did not impact on the quality of the therapy deliv-
ered, however, the research conducted in South Africa included
nurses, rather than clinical officers, and this is likely to differ from
treatment delivered in other country settings.
Pragmatic trials providedmost of the data for this review, including
both task shifting within facilities and to the community. These
trials are designed to include real-life settings and be applicable to
general clinical care.
The observational studies included in the review represented large
cohorts of task shifting care, however, there was substantial het-
erogeneity in the settings and models of care delivered. This may
introduce bias, particularly in the selection of the populations,
and reporting of outcomes. A key concern for the interpretation
of these studies is that individuals could choose whether to be
treated by a physician or not and whether to be down referred, by
decentralised services, but the methods for this decision were not
clearly reported. In addition, the quality of data collection in these
studies is variable, and generally based on a secondary analysis of
routinely collected programme data. Of concern is that the mod-
els of care, including health care provider training, supervision
and mentoring and the necessary organisational planning that is
required, were likely to differ across the studies. Even within the
cohorts, there is a possibility that task shifting did not occur in a
systematic way.
Quality of the evidence
In the GRADE system, well-conducted randomised controlled
trials (without additional limitations) provide high quality evi-
dence, andobservational studieswithout any special strengths (and
without additional limitations) provide low-quality evidence. The
quality of evidence provided by a body of literature comprised ex-
clusively of observational studies would thus generally be graded
as low, except in circumstances where observational studies are up-
graded. For this review randomised controlled trials were available
to address the critical outcomes including death, loss to follow-up
and the composite outcome, attrition (death plus loss to follow-
up).
The results of all key outcomes are provided by randomised con-
trolled trials.The trial evaluating doctors compared to nurses for
initiation and maintenance of therapy, provided high quality ev-
idence that there is likely no difference in the rates of death and
attrition, and moderate quality evidence of fewer losses to follow-
up with nurse-led care. The trials were methodologically sound
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and rated to have low risk of bias regarding their conduct, however,
the issue of contamination could not be excluded. In addition,
adjusting the sample size to account for the cluster design, intro-
duced a degree of imprecision which required that we downgrade
the evidence quality some of the outcomes.
The trials evaluating doctors compared to nurses for maintenance
of therapy, provided moderate quality evidence that there is likely
no difference in the rates of death, loss to follow-up and attrition
with nurse-led care. The evidence was downgraded for impreci-
sion, due to the low number of event rates and wide confidence
intervals including appreciable harm or benefit.
The cohorts included in the review provided low or very low qual-
ity evidence, due to their inherent biases with cohort study design
and at times imprecision despite the large sample sizes.
Potential biases in the review process
Biases in the review process were minimised by performing a com-
prehensive search of databases and conference proceedings, not
limiting for language or time. In addition, we contacted expert
researchers in the field and other experts associated with relevant
organisations for unpublished and ongoing studies. We did not
explore publication bias by using funnel plots as there were too
few studies to draw conclusions from this analysis.
Agreements and disagreements with other
studies or reviews
The high levels of healthcare worker shortage is recognised as a se-
vere impediment to increasing expansion of patients access to an-
tiretroviral therapy. In response there has been substantial research
published regarding the issue of task shifting in HIV care. A prior
narrative reviewof task shifting found similar outcomes comparing
physician and non-physician led care (Callaghan 2010), however,
there was not a systematic approach to interrogating the quality
of the included studies. A systematic review evaluating commu-
nity-based antiretroviral therapy programs was published in 2013
(Decroo 2013), however, their question differed from ours as their
comparator was not specifically doctor led treatment. They also
included a variety of study designs to answer their review ques-
tion, however, they did not evaluate the quality of included studies
which may result in bias in the reporting of their results.Another
systematic review, including a meta-analysis of death, loss to fol-
low-up and immunological and virological outcomes had simi-
lar findings to our review (Emdin 2013). The researchers found
that death was no different and loss to follow-up possibly im-
proved when nurses initiated antiretroviral management. How-
ever, it should be noted that their approach differed fromCochrane
standard methods and their review pooled a variety of study de-
signs which may introduce bias in the meta-analysis.
In addition, decentralisation of care often includes task shifting as
part of the model of care, whereas task shifting may or may not
occur with decentralisation. A recent Cochrane review of decen-
tralisation reports similar evidence of the relative feasibility of de-
centralisation care, including at times task shifting (Kredo 2013).
In June 2013, the WHO launched their consolidated guidelines
for managing HIV using a public health approach. It includes
reference to operational changes that are recommended to improve
access to and retention in care, including task shifting of care to
non-physicians (Hirnschall 2013).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
There is moderate quality evidence that substitution of nurses
or community workers for doctors to initiate and maintain ART
in adults in lower- and middle-income countries is feasible and
probably does not compromise the quality of care provided. We
did not find studies that included special risk groups (e.g. pregnant
women, children) to inform practice for these populations.
For programme managers and policy makers considering the ap-
plication of the results, implementation strategies should carefully
consider the models of care that were used. The pragmatic trial
designs are more likely than typical trials to reflect real life treat-
ment programmes and settings that roll-out treatment. However,
the researchers stress the importance of adequate training and the
need for organisational structures to support the shifting of tasks to
ensure high quality clinical care. This approach of supporting and
mentoring staff to take on additional tasks is aligned with broader
issues of strengthening of health services and reducing work load
for the sparse numbers of doctors.
Successful application of task shifting is likely to require leadership
from national governments in harnessing multiple stakeholders
to buy-in to these concepts and create enabling regulatory frame-
works to support sustainable, cost-effective, equitable models rel-
evant for each country setting. This must crucially include clarify-
ing roles of different cadres of health workers, changed scopes of
practice and related regulatory frameworks. This reconfiguration
of health teams, needs to avoid fragmentation and consider long
term views of health system strengthening.
Implications for research
All of the critical outcomes for this review have been addressed
by randomised controlled trial data. However, two of the trials
that contributed most of the data were set in South Africa, where
management was shifted from doctors to nurses. Thus data on the
inclusion on task shifting to clinical officers is limited to cohort
data. The cohort data included in the review does provide evidence
of the feasibility of running HIV programmes incorporating non-
physician based care.
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Further research, using pragmatic clinical trial designs, should ex-
plore the specificmodels of care and the health careworkers that are
best suited to various settings in lower andmiddle-income country
settings. In addition, where appropriate, special risk groups (e.g.
children) should be investigated, and the programmatic require-
ments specific for them clearly described.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Assefa 2012
Methods Design: retrospective cohort
Duration of study: recruitment September 2006 - 2008, censored March 2009 (minimum 6
months, maximum 24 months follow-up)
Participants Country: Ethiopia
Setting: nationwide, 30 hospitals, 25 health centres
Inclusion and exclusion criteria: nil described
Comparable CD4 count or clinical stage at baseline: similar CD4 count
Interventions Intervention: patients initiated and maintained at health centres by nurses and health officers.
Severe manifestations, treatment failures were referred to hospital.
Control: initiated and followed up at hospital with physicians.
Co-interventions: community health workers performed counselling, referrals and linkage
between facilities and defaulter tracing in both groups
Outcomes Mortality, loss to follow-up, retention, and median CD4 Count.
Assessed at 6, 12 and 24 months
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Baseline CD4 count (All studies) Low risk Similar median CD4 count in both groups
Other baseline variables (All studies) Unclear risk Not described
Co- interventions (All studies) Unclear risk Community health workers delivered adher-
ence and referral services from health centres
to hospitals, unclear whether this was for both
groups or for the health centre group only
Data collection (Cohorts) High risk Retrospective cohort
Patient selection bias (Cohorts) Low risk Randomly selected folders in all included sites
in both groups
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Bedelu 2007
Methods Design: retrospective cohort
Duration: January 2004 - June 2005, completed 12 months follow-up by July 2006
Participants Country: South Africa
Setting: rural, 12 health centres, 1 hospital
inclusion criteria: adults eligible for ART CD4 count <200cells/mm3, WHO clinical stage 4
exclusion criteria: nil described
Comparable CD4 count or clinical stage at baseline: CD4 counts differed at baseline
Interventions Intervention: initiated and maintained antiretroviral therapy at health centre by nurses, physi-
cian support with mobile team, adherence counsellors and patient support groups available.
Control: initiated and maintained antiretroviral therapy at hospital by doctors
Outcomes Mortality, loss to follow-up, CD4 count, viral load
Assessed at 12 months
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Baseline CD4 count (All studies) High risk CD4 counts differed between groups at base-
line.
Other baseline variables (All studies) Unclear risk Only reported on sex
Co- interventions (All studies) High risk Model differed by group, Nurse (health cen-
tre) group received additional adherence sup-
port and visits from a mobile support team of
experienced clinicians
Data collection (Cohorts) High risk Retrospective cohort
Patient selection bias (Cohorts) Low risk No selection bias identified
Brennan 2011
Methods Design: retrospective matched cohort analysis
Duration: April 2004 - January 2009
Participants Country: South Africa.
Setting: peri-urban, urban, 1 hospital, 1 clinic.
Inclusion criteria: stable on antiretroviral treatment for at least 11 months, no opportunistic
infections, CD4 count > 200cells/mm3, stable weight and virologically suppressed <400
copies/mL. Considered good candidates by doctors and agree to down-refer.
Exclusion criteria: refuse down-referral
Comparable CD4 count or clinical stage at baseline: control matched on sex, age, months on
Rx, regimen, BMI, HB and CD4 count (propensity scoring)
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Interventions Intervention: initiated at advanced hospital by doctors, maintained at health centre by nurses,
seen every 2months formedicine pick up. “Up referred” if default (>7days), toxicity, detectable
viral load
Control: initiated and maintained by doctor at advanced hospital, seen 6 monthly, pick up
medicines every 2 months.
Co-interventions: adherence counselling provided at both facilities
Outcomes Death, loss to follow-up, mean CD4 count, viral load rebound.
Assessed at 12 months
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Baseline CD4 count (All studies) Low risk Similar CD4 count in both groups.
Other baseline variables (All studies) Low risk Matched by Propensity scores on all baseline
characteristics
Co- interventions (All studies) Low risk Both groups received adherence counselling.
Data collection (Cohorts) High risk Retrospective cohort.
Patient selection bias (Cohorts) Low risk All participants were equally eligible for down
referral, and were matched using propensity
scores on baseline characteristics
Fairall 2012
Methods Design: pragmatic Cluster randomised trial.
Duration of study: recruitment and enrolment January 2008- June 2009. Each patient’s
follow-up was censored between 12 and 18 months after enrolment
Participants Country: Free state, South Africa.
Setting: rural, Periurban, 30 nurse led primary care clinics.
Inclusion criteria: the study enrolled two different cohorts.
1) Adult patients (≥16 years) with CD4 counts between 200 and 350 cells and not yet
started on ART
2) adults already on ART for at least six months, still on treatment at the time of enrolment.
Exclusion Criteria: eligible patients who did not return for a follow up clinic appointment
after enrolment on ART
Interventions Intervention 1: patients in Cohort 1 were monitored by nurses till they became eligible for
ART which was then initiated by designated nurses and subsequently monitoring as well
as re-prescriptions done by the nurses. Nurses did not initiate ART in patients meeting
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the following criteria but referred them to the doctor; (CD4 < 50, Stage 4 AIDS, previous
ART, bed- or wheelchair-bound, using drugs other than cotrimoxazole or vitamins, pregnant,
weight < 40 kg or body mass index >28)
Intervention 2: patients in cohort 2 were followed up by nurses for monitoring as well as re-
prescription of ART
Control: Patients eligible for ARTwere referred to a doctor to initiate and repeat prescriptions
for ARTand review patients every six months. Between visits to doctors, patients were seen
monthly by nurses
Co-interventions: as part of the STRETCH intervention, nurses received four educational
outreach sessions using PALSA PLUS guidelines. The training related to; ART prescribing
and side effects, practice guidelines/ algorithms as well as identifying patients needing referral
to a doctor. Managerial support was also provided by STRETCH coordinators
Outcomes Cohort 1:
Primary: time to death.
Secondary: change in weight, CD4, viral loads; hospital admissions, and inpatient days; ART
initiation, time from enrolment to starting ART, detection of tuberculosis, cotrimoxazole
provision, program retention one year after enrolment, baseline CD4 count among those
who started ART, and clinic consultations with nurses and doctors
Cohort 2:
Primary: viral load suppression 12 months after enrolment
Secondary: time to death censored between 12 and 18 months after enrolment, changes in
weight and CD4 counts, hospital admissions, and inpatients days; programme retention,
diagnosis of tuberculosis, cotrimoxazole provision, ART regimen switching, and clinic con-
sultations with nurses and doctors
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Baseline CD4 count (All studies) Low risk Both groups had similar CD4 counts in co-
hort 1.
Other baseline variables (All studies) Unclear risk STRETCH group had higher proportion of
WHO clinical stage I and fewer patients with
WHO clinical stage III in Cohort 1
Co- interventions (All studies) Low risk The intervention groups received additional
training and support as part of the implemen-
tation of the guideline, compared to provi-
sion of the guideline to the control groups.
However this was part of the model of care
being tested
Random sequence generation (Trials) Low risk Randomisation was carried out by the trial
statistician before the trial started, using N-
Query Advisor
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Allocation concealment (Trials) Low risk Randomisation conducted centrally by statis-
tician prior to the start of the trial
Contamination Protection (Trials) Unclear risk During the trial, some of the control clinics
received input from additional doctors sent
by the provincial administration, with poten-
tial contamination bias
Humphreys 2010
Methods Design: prospective cohort.
Duration: started recruitment January 2007 - June 2007, followed up until November 2007,
minimum 6 months follow up
Participants Country: Swaziland
Setting: rural setting, one district hospital, 30 nurse led health centres.
Inclusion criteria: adults >14 years on antiretroviral therapy for at least 4 weeks, CD4 count
>100 cells/mm3.
Exclusion criteria: refused to be down referred.
Comparable CD4 count or clinical stage at baseline: CD4 count and clinical stage similar at
baseline
Interventions Intervention: initiated at hospital by doctor and maintained at health centre by nurses.
Control: initiated and maintained at hospital by doctors.
Co-interventions: training for primary care centre nurses, monthly outreach support visit by
at least one counsellor and nurse
Outcomes Clinic attendance, patient experience, loss to follow up, change in CD4 count, weight, death
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Baseline CD4 count (All studies) Low risk Similar mean CD4 between groups.
Other baseline variables (All studies) Low risk Age, sex, and weight were similar at base-
line, durationon antiretrovirals (longer for the
control group) and and length of follow up
differed by groupwhichmay favour outcomes
in the control group
Co- interventions (All studies) Low risk No additional intervention described, other
than monthly mobile support team visits
which are part of the model of care
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Data collection (Cohorts) Low risk Prospective cohort
Patient selection bias (Cohorts) Low risk Assignmentwas based on catchment areas (in-
tervention clinics/control clinics)
Jaffar 2009
Methods Design: cluster randomised trial, 22 clusters for each arm, median size 25 - 36, inter-cluster
co-efficient 0.2
Duration: February 2005 -December 2006, follow-up until 31 January 2009,median follow-
up 27 - 28 months
Participants Country: Uganda.
Setting: urban, peri-urban and rural, varying distance from the hospital.
Inclusion criteria: adults >18 years old, CD4 count <200cells/mm3, WHO clinical stage 3
or 4.
Exclusion criteria: living >100 km from facility.
Comparable CD4 count or clinical stage at baseline: similar, slightly lower CD4 count for
intervention arm
Interventions Intervention: initiated at hospital by doctors, maintained in community by field officers
who delivered treatments every month on motorcycles, monitored adherence, drug toxicity
and disease, they referred patients; had access to mobile phones for on-site call to doctor. If
patients was absent, followed up. Reviewed at hospital 6 monthly.
Control: initiated and maintained at hospital. Monthly clinic visits to collect medicine,
reviewed by medical officer 3 monthly, drop in clinic; if defaulted, followed up at home;
household vouchers for counselling
Outcomes Rate of virological failure, time to detectable viral load >500 copies/mL, time to detectable
viral load >500 copies/mL at any visit from 12 months if it was <500 copies/mL at 6 months
or increase in 1000 copies/mL between two consecutive tests in those who did not have viral
load <500 copies/ mL at 6 months, all cause mortality, admission, change to second line
antiretrovirals, outpatient attendance, adherence in previous 28 days, cost incurred by health
services and patients, patient diagnosed with TB at first admission, proportion of those with
CD4 count > 200cells/mm3.
Timepoints of outcome assessment not clear.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Baseline CD4 count (All studies) Low risk Similar, slightly lower CD4 count for inter-
vention arm.
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Other baseline variables (All studies) Low risk Similar baseline characteristics for both
groups.
Co- interventions (All studies) Low risk model of care in both groups differed by fa-
cility.
Random sequence generation (Trials) Unclear risk Not described.
Allocation concealment (Trials) Low risk Allocation cards labelled with stratum num-
ber and sealed in advance was drawn from
a concealed box in the presence of all stake-
holders
Contamination Protection (Trials) Low risk No evidence of contamination.
Kipp 2010
Methods Design: prospective cohort.
Duration: six month results available (follow up for 2 years)
Participants Country: Rwimi, Uganda.
Setting: intervention in rural setting, control in urban setting.
Inclusion criteria: adults >18 years, eligible for antiretroviral therapy, antiretroviral therapy
naive, resident in the sub-county.
Exclusion criteria: nil described.
Comparable CD4 count or clinical stage at baseline: similar CD4 count at baseline
Interventions Intervention: initiated at the health centre, maintained in community volunteer community
health workers who did weekly home visits - anti-retrovirals delivered monthly, adherence
monitored and supported, monitored adverse effects and clinical symptoms.
Control: initiated and maintained in hospital, by doctors.
Co-intervention: an additional treatment support was required by those in the home-based
group to support adherence and disclosure
Outcomes Mortality, viral load, increase in CD4 count, cost to provider.
Assessed at 6 months
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Baseline CD4 count (All studies) Low risk Similar mean CD4 count in both groups
Other baseline variables (All studies) Low risk Age and sex similar at baseline, although oc-
cupations different
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Co- interventions (All studies) High risk Treatment supporter was required by home
based care (intervention) group
Data collection (Cohorts) Low risk Prospective
Patient selection bias (Cohorts) Low risk No selection bias identified
Kiweewa 2013
Methods Design: open label randomised non inferiority trial
Duration: mean duration of follow-up was 10 months.
57% were followed up for 12 months following ART initiation while 43% were followed up
for only 6 months
Participants Country: Kampala, Uganda
Setting: urban, Mulago National Referral Hospital at comprehensive ART clinic attached to
the PMTCT unit within the reproductive child health clinic
Inclusion criteria: HIV infected pregnant women referred from PMTCT programme before
or after delivery initiated on ART, 18 years or older, written informed consent, residence in
a stable home within 15km of Mulago hospital, willingness to be home visited,eligibility to
start ART based on Ugandan ministry of health guidelines at that time (WHO clinical stage
3 or 4 or CD4 count <200cells/mm3
Exclusion criteria: lack of willingness to be home visited, lack of interest or busy schedule,
working or staying upcountry, ineligibility for ART
Comparable CD4 count or clinical stage at baseline: CD4 count and clinical stage similar at
baseline
Interventions Intervention: initiated by doctor, then seen at 2 months and 12 months by doctor - but at
2 weeks, 1, 3, 6, 9 months seen by nurses and peer counsellors. Home visits made if missed
appointment; counsellors were PLWH with 10 day training, nurses had special training on
HIV ART management
Control: initiated in hospital by doctors, maintained by doctors and certified adherence
counsellors (standard of care; seen monthly at the hospital)
Outcomes Primary outcome: virological success (viral load ,400 copies/mL at 6 -12 months after initi-
ation)
Secondary outcomes: mean increase in CD4 count; drug adherence through pill counts at 6
- 12 months after initiation of ART
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Baseline CD4 count (All studies) Low risk Similar mean CD4 count in both groups
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Other baseline variables (All studies) Low risk Similar baseline characteristics for both
groups
Co- interventions (All studies) Low risk The intervention group received home visits
for those who missed clinic appointments as
part of themodel of care.However, since there
was no loss to follow up in either group, this
was not considered a significant source of bias
which would impact an outcome
Random sequence generation (Trials) Low risk Randomisation was done using a table of ran-
dom numbers
Allocation concealment (Trials) Low risk The allocation codes for a particular site were
sealed in sequentially numbered envelopes
Contamination Protection (Trials) Unclear risk No information was provided on measures to
avoid contamination
Sanne 2010
Methods Design: open label randomised non inferiority trial
Duration of study: median follow-up 120 weeks
Participants Country: South Africa.
Setting: peri-urban in 2 Primary health clinics in Cape town and Johannesburg.
Inclusion criteria: adults (>16 years), with a CD4 count < 350cells/mm3 or with a previous
AIDS Defining illness, who had taken ART for < 6 weeks.
Exclusion Criteria: pregnant and in the 1st trimester. Renal, liver and hematology values
>3 times the ULN; concomitant treatment with systemic myelosuppressive, neurotoxic,
pancreatotoxic, hepatotoxic or cytotoxic treatment within 30 days of randomisation; acute
hepatitis, intractable diarrhoea lasting >6 weeks; Bilateral peripheral neuropathy grade 2 or
higher, Current alcohol or substance abuse that, in the opinion of the investigators, would
interfere with the study, patients with an active OI <7 days treatment, TB if treatment was
less than 8 weeks or <2 weeks if recruited after Oct 2005.
Comparable CD4 count or clinical stage at baseline: similar CD4 count at baseline
Interventions Intervention: ART maintenance care by primary health care nurses (With additional 1year
training in primary care) in Primary health clinics.
Control: ART maintenance care from doctors ( medical officers with no previous HIV-care
experience) in Primary health clinics.
Both groups had ART initiated by doctors in Primary health clinics.
Co-interventions: both groups received adherence counselling by a team of lay community
counsellors who were trained in treatment adherence counselling
Outcomes Cumulative treatment failure, defined as a composite endpoint consisting of virologic failure,
toxicity failure, withdrawn consent, defaulting clinic schedule, loss to follow-up, disease
progression, and death.
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Cumulative virologic failure, defined by viral load decline of less than 1.5 log after 12 weeks
of treatment OR 2 viral load measures of greater than 1,000 copies/ml on 2 consecutive
occasions more than 4 weeks apart after 24 weeks of treatment.
CD4 count increase.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Baseline CD4 count (All studies) Low risk CD4 count was similar in both groups.
Other baseline variables (All studies) Low risk Both groups had similar baseline characteris-
tics
Co- interventions (All studies) Low risk Both groups received adherence counselling
from lay community counsellors
Random sequence generation (Trials) Low risk Randomisation lists were generated centrally
with a stratified permuted block randomisa-
tion
Allocation concealment (Trials) Low risk The allocation codes for a particular site were
sealed in sequentially numbered envelopes
Contamination Protection (Trials) Low risk To limit contamination between randomised
groups, work activity and monitoring sched-
ules were separated with routine visits sched-
uled on different days of the week
Sherr 2010
Methods Design: retrospective cohort.
Duration of study: Enrolled for ART between July 2004 and October 2007
Participants Country: Mozambique.
Setting: two public sector ambulatory HIV clinics in urban central Mozambique (both clinics
situated in Central and Provincial Hospitals).
Inclusion criteria: ART-naive adult patients initiating ART during study period.
Exclusion Criteria: <15 years of age, pregnant, patients whose initial physician was an expa-
triate physician.
Comparable CD4 count or clinical stage at baseline: similar CD4 count at baseline
Interventions Intervention: patients whose initial provider at clinic enrolment was a clinical officer (Non
physician clinician).
Control:patients whose initial provider at clinic enrolment was a Doctor (Specialist or Gen-
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eralist).
Co-intervention: both groups had free access to preferred provider (doctor or clinical officer)
during the study period
Outcomes Proportion with CD4 evaluated, (90 to 210 days and 330 to 390 days post ART initiation),
Loss to follow up, Adherence to ART, a clinical visit at least once per quarter for three of the
first four quarters post-ART initiation
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Baseline CD4 count (All studies) Low risk Similar CD4 count at baseline.
Other baseline variables (All studies) Low risk Similar baseline characteristics except control
patients were more likely to be of higher so-
cioeconomic status
Co- interventions (All studies) High risk Patient in both groups had free access to
provider of choice. 27% clinical officer group
switched to the Doctor group while 39.4%
in Doctor group switched to clinical officer
group
Data collection (Cohorts) High risk Retrospective cohort
Patient selection bias (Cohorts) Unclear risk Assignment of patients to clinical provider
was at “clinic discretion”
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Babigumira 2009 Modeling study
Bemelmans 2010 Descriptive. No clear comparison between doctor-led management and non-doctor led management of ART
Boulle 2013 Both groups were seen by doctors and nurses. Outcome analysed was consultant ratio
Celletti 2010 Analysis of regulatory framework
Chang 2010 Not comparing doctor led care versus non-doctor led care
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Chang 2011 Mixed methods study, not comparing doctor led care versus non-doctor led care
Colvin 2010 Descriptive study for STRETCH (Fairall 2012)
Connolly 2013 Comparison groups not clearly doctor vs. nurse care.
de Wet 2011 Purely qualitative study.
Dewo 2012 No control arm evident.
Georgeu 2012 Purely qualitative process evaluation of the STRETCH trial. No results by arm
Ivers 2011 Mapping descriptive study in Haiti.
Labhardt 2012 decentralisation study, not evident if task shifting included in the model
Matovuu 2013 Duplicate of Kiweewa trial, already included
McGuire 2013 Mixed care groups, not doctor vs. nurse.
Morris 2009 Descriptive study of programme in Zambia.
Nyasulu 2013 Interrupted time series design. No contemporary arms
O’Malley 2014 Mixed methods study.
Rasschaert 2011 Descriptive study in Malawi and Ethiopia.
Selke 2010 Limited access to doctor in control arm.
Sherr 2009 Descriptive. Sub study of Sherr 2010.
Simoni 2011 Adherence support, not comparing doctor led care versus other carer
Torpey 2008 Cross-sectional study.
Uebel 2011 Descriptive. Substudy to Fairall 2012.
Van Rie 2014 Historical control group.
Vasan 2009 Qualitative study of agreement between health workers.
Venkatesh 2010 Case control study design.
Zachariah 2009 Descriptive study.
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D A T A A N D A N A L Y S E S
Comparison 1. Doctor versus nurse or clinical officer (initiation and Maintenance of ART)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Death (12 months) 3 Risk Ratio (IV, Random, 95% CI) Subtotals only
1.1 Initiation and
maintenance of ART (RCTs)
1 2770 Risk Ratio (IV, Random, 95% CI) 0.96 [0.82, 1.12]
1.2 Initiation and
maintenance of ART (Cohort)
2 39160 Risk Ratio (IV, Random, 95% CI) 1.23 [1.14, 1.33]
2 Lost to follow-up (12 months) 3 Risk Ratio (IV, Random, 95% CI) Subtotals only
2.1 Initiation and
maintenance of ART (RCTs)
1 2770 Risk Ratio (IV, Random, 95% CI) 0.73 [0.55, 0.97]
2.2 Initiation and
maintenance of ART (Cohorts)
2 39156 Risk Ratio (IV, Random, 95% CI) 0.30 [0.05, 1.94]
3 Death or lost to follow-up
(12months)
3 Risk Ratio (IV, Random, 95% CI) Subtotals only
3.1 Initiation and
Maintenance of ART (RCT)
1 2770 Risk Ratio (IV, Random, 95% CI) 0.89 [0.79, 1.01]
3.2 Initiation and
Maintenance of ART (Cohorts)
2 39160 Risk Ratio (IV, Random, 95% CI) 0.72 [0.48, 1.07]
4 Cost of travel Other data No numeric data
4.1 cost of travel Other data No numeric data
Comparison 2. Doctor versus nurse or clinical officer (Maintenance of ART)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Death (12 months) 3 Risk Ratio (M-H, Random, 95% CI) Subtotals only
1.1 Maintenance of ART
(RCTs)
2 4332 Risk Ratio (M-H, Random, 95% CI) 0.89 [0.59, 1.32]
1.2 Maintenance of ART
(Cohorts)
1 2772 Risk Ratio (M-H, Random, 95% CI) 0.19 [0.05, 0.78]
2 Lost to follow-up (12 months) 3 Risk Ratio (IV, Random, 95% CI) Subtotals only
2.1 Maintenance of ART
(RCTs)
2 4332 Risk Ratio (IV, Random, 95% CI) 1.27 [0.92, 1.77]
2.2 Maintenance of ART
(Cohorts)
1 2772 Risk Ratio (IV, Random, 95% CI) 0.34 [0.18, 0.66]
3 Death or lost to follow-up (12
months)
3 Risk Ratio (IV, Random, 95% CI) Subtotals only
3.1 Maintenance of ART
(RCT)
2 4332 Risk Ratio (IV, Random, 95% CI) 1.10 [0.86, 1.41]
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3.2 Maintenance of ART
(Cohorts)
1 2772 Risk Ratio (IV, Random, 95% CI) 0.30 [0.17, 0.54]
Comparison 3. Doctor versus community health worker
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Death (12 months) 2 Risk Ratio (M-H, Random, 95% CI) Subtotals only
1.1 Maintenance of ART in
community (RCTs)
1 559 Risk Ratio (M-H, Random, 95% CI) 1.00 [0.62, 1.62]
1.2 Maintenance of ART in
community (Cohort)
1 385 Risk Ratio (M-H, Random, 95% CI) 1.44 [0.81, 2.57]
2 Lost to follow-up (12 months) 2 Risk Ratio (M-H, Random, 95% CI) Subtotals only
2.1 Maintenance of ART in
community (RCTs)
1 559 Risk Ratio (M-H, Random, 95% CI) 0.52 [0.12, 2.30]
2.2 Maintenance of ART in
community (Cohorts)
1 385 Risk Ratio (M-H, Random, 95% CI) 1.49 [0.81, 2.74]
3 Death or lost to follow-up (12
months)
2 Risk Ratio (IV, Random, 95% CI) Subtotals only
3.1 Maintenance of ART in
community (RCTs)
1 559 Risk Ratio (IV, Random, 95% CI) 0.93 [0.60, 1.46]
3.2 Maintenance of ART in
community (Cohorts)
1 385 Risk Ratio (IV, Random, 95% CI) 1.46 [0.98, 2.17]
4 Cost to patient Other data No numeric data
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Analysis 1.1. Comparison 1 Doctor versus nurse or clinical officer (initiation and Maintenance of ART) ,
Outcome 1 Death (12 months).
Review: Task shifting from doctors to non-doctors for initiation and maintenance of antiretroviral therapy
Comparison: 1 Doctor versus nurse or clinical officer (initiation and Maintenance of ART)
Outcome: 1 Death (12 months)
Study or subgroup Task-shifting Doctor care Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Initiation and maintenance of ART (RCTs)
Fairall 2012 (1) 299/1614 224/1156 100.0 % 0.96 [ 0.82, 1.12 ]
Subtotal (95% CI) 1614 1156 100.0 % 0.96 [ 0.82, 1.12 ]
Total events: 299 (Task-shifting), 224 (Doctor care)
Heterogeneity: not applicable
Test for overall effect: Z = 0.57 (P = 0.57)
2 Initiation and maintenance of ART (Cohort)
Assefa 2012 698/6206 2915/31929 93.6 % 1.23 [ 1.14, 1.33 ]
Bedelu 2007 100/595 58/430 6.4 % 1.25 [ 0.92, 1.68 ]
Subtotal (95% CI) 6801 32359 100.0 % 1.23 [ 1.14, 1.33 ]
Total events: 798 (Task-shifting), 2973 (Doctor care)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.01, df = 1 (P = 0.94); I2 =0.0%
Test for overall effect: Z = 5.44 (P < 0.00001)
0.005 0.1 1 10 200
Favours task-shifting Favours doctor care
(1) Average cluster size calculated to be 235, intra-cluster correlation coefficient = 0.01, design effect = 3.34
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Analysis 1.2. Comparison 1 Doctor versus nurse or clinical officer (initiation and Maintenance of ART) ,
Outcome 2 Lost to follow-up (12 months).
Review: Task shifting from doctors to non-doctors for initiation and maintenance of antiretroviral therapy
Comparison: 1 Doctor versus nurse or clinical officer (initiation and Maintenance of ART)
Outcome: 2 Lost to follow-up (12 months)
Study or subgroup Task-shifting Doctor care Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Initiation and maintenance of ART (RCTs)
Fairall 2012 (1) 91/1614 89/1156 100.0 % 0.73 [ 0.55, 0.97 ]
Subtotal (95% CI) 1614 1156 100.0 % 0.73 [ 0.55, 0.97 ]
Total events: 91 (Task-shifting), 89 (Doctor care)
Heterogeneity: not applicable
Test for overall effect: Z = 2.16 (P = 0.031)
2 Initiation and maintenance of ART (Cohorts)
Assefa 2012 1407/6202 9535/31929 51.2 % 0.76 [ 0.72, 0.80 ]
Bedelu 2007 13/595 83/430 48.8 % 0.11 [ 0.06, 0.20 ]
Subtotal (95% CI) 6797 32359 100.0 % 0.30 [ 0.05, 1.94 ]
Total events: 1420 (Task-shifting), 9618 (Doctor care)
Heterogeneity: Tau2 = 1.77; Chi2 = 42.35, df = 1 (P<0.00001); I2 =98%
Test for overall effect: Z = 1.27 (P = 0.21)
0.01 0.1 1 10 100
Favours task-shifting Favours doctor care
(1) Average cluster size calculated to be 235, intra-cluster correlation coefficient = 0.01, design effect = 3.34
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Analysis 1.3. Comparison 1 Doctor versus nurse or clinical officer (initiation and Maintenance of ART) ,
Outcome 3 Death or lost to follow-up (12months).
Review: Task shifting from doctors to non-doctors for initiation and maintenance of antiretroviral therapy
Comparison: 1 Doctor versus nurse or clinical officer (initiation and Maintenance of ART)
Outcome: 3 Death or lost to follow-up (12months)
Study or subgroup Task-shifting Doctor care Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Initiation and Maintenance of ART (RCT)
Fairall 2012 390/1614 313/1156 100.0 % 0.89 [ 0.79, 1.01 ]
Subtotal (95% CI) 1614 1156 100.0 % 0.89 [ 0.79, 1.01 ]
Total events: 390 (Task-shifting), 313 (Doctor care)
Heterogeneity: not applicable
Test for overall effect: Z = 1.74 (P = 0.082)
2 Initiation and Maintenance of ART (Cohorts)
Assefa 2012 2105/6206 12450/31929 53.5 % 0.87 [ 0.84, 0.90 ]
Bedelu 2007 113/595 141/430 46.5 % 0.58 [ 0.47, 0.72 ]
Subtotal (95% CI) 6801 32359 100.0 % 0.72 [ 0.48, 1.07 ]
Total events: 2218 (Task-shifting), 12591 (Doctor care)
Heterogeneity: Tau2 = 0.08; Chi2 = 13.45, df = 1 (P = 0.00024); I2 =93%
Test for overall effect: Z = 1.62 (P = 0.11)
Test for subgroup differences: Chi2 = 1.02, df = 1 (P = 0.31), I2 =1%
0.01 0.1 1 10 100
Favours task-shifting Favours doctor care
Analysis 1.4. Comparison 1 Doctor versus nurse or clinical officer (initiation and Maintenance of ART) ,
Outcome 4 Cost of travel.
Cost of travel
Study Down referred patient Hospital care patient P-value
cost of travel
Humphreys 2010 average cost for follow up care -
USD 0.74
average cost for follow up care USD
1.5
P = 0.001
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Analysis 2.1. Comparison 2 Doctor versus nurse or clinical officer (Maintenance of ART), Outcome 1 Death
(12 months).
Review: Task shifting from doctors to non-doctors for initiation and maintenance of antiretroviral therapy
Comparison: 2 Doctor versus nurse or clinical officer (Maintenance of ART)
Outcome: 1 Death (12 months)
Study or subgroup Task-shifting Doctor care Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Maintenance of ART (RCTs)
Fairall 2012 (1) 37/1711 42/1809 84.6 % 0.93 [ 0.60, 1.44 ]
Sanne 2010 6/404 9/408 15.4 % 0.67 [ 0.24, 1.87 ]
Subtotal (95% CI) 2115 2217 100.0 % 0.89 [ 0.59, 1.32 ]
Total events: 43 (Task-shifting), 51 (Doctor care)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.33, df = 1 (P = 0.57); I2 =0.0%
Test for overall effect: Z = 0.59 (P = 0.55)
2 Maintenance of ART (Cohorts)
Brennan 2011 2/693 32/2079 100.0 % 0.19 [ 0.05, 0.78 ]
Subtotal (95% CI) 693 2079 100.0 % 0.19 [ 0.05, 0.78 ]
Total events: 2 (Task-shifting), 32 (Doctor care)
Heterogeneity: not applicable
Test for overall effect: Z = 2.30 (P = 0.021)
0.01 0.1 1 10 100
Favours task-shifting Favours doctor care
(1) Average cluster size 155, ICC = 0.005, design effect = 1.77
52Task shifting from doctors to non-doctors for initiation and maintenance of antiretroviral therapy (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 2.2. Comparison 2 Doctor versus nurse or clinical officer (Maintenance of ART), Outcome 2 Lost
to follow-up (12 months).
Review: Task shifting from doctors to non-doctors for initiation and maintenance of antiretroviral therapy
Comparison: 2 Doctor versus nurse or clinical officer (Maintenance of ART)
Outcome: 2 Lost to follow-up (12 months)
Study or subgroup Task-shifting Doctor care Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Maintenance of ART (RCTs)
Fairall 2012 (1) 70/1711 59/1809 94.6 % 1.25 [ 0.89, 1.76 ]
Sanne 2010 5/404 3/408 5.4 % 1.68 [ 0.40, 7.00 ]
Subtotal (95% CI) 2115 2217 100.0 % 1.27 [ 0.92, 1.77 ]
Total events: 75 (Task-shifting), 62 (Doctor care)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.15, df = 1 (P = 0.69); I2 =0.0%
Test for overall effect: Z = 1.44 (P = 0.15)
2 Maintenance of ART (Cohorts)
Brennan 2011 10/693 87/2079 100.0 % 0.34 [ 0.18, 0.66 ]
Subtotal (95% CI) 693 2079 100.0 % 0.34 [ 0.18, 0.66 ]
Total events: 10 (Task-shifting), 87 (Doctor care)
Heterogeneity: not applicable
Test for overall effect: Z = 3.22 (P = 0.0013)
0.01 0.1 1 10 100
Favours task-shifting Favours doctor care
(1) Average cluster size 155, ICC = 0.005, design effect = 1.77
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Analysis 2.3. Comparison 2 Doctor versus nurse or clinical officer (Maintenance of ART), Outcome 3 Death
or lost to follow-up (12 months).
Review: Task shifting from doctors to non-doctors for initiation and maintenance of antiretroviral therapy
Comparison: 2 Doctor versus nurse or clinical officer (Maintenance of ART)
Outcome: 3 Death or lost to follow-up (12 months)
Study or subgroup Task-shifting Doctor care Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Maintenance of ART (RCT)
Fairall 2012 107/1711 101/1809 90.3 % 1.12 [ 0.86, 1.46 ]
Sanne 2010 11/404 12/408 9.7 % 0.93 [ 0.41, 2.07 ]
Subtotal (95% CI) 2115 2217 100.0 % 1.10 [ 0.86, 1.41 ]
Total events: 118 (Task-shifting), 113 (Doctor care)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.19, df = 1 (P = 0.66); I2 =0.0%
Test for overall effect: Z = 0.74 (P = 0.46)
2 Maintenance of ART (Cohorts)
Brennan 2011 12/693 119/2079 100.0 % 0.30 [ 0.17, 0.54 ]
Subtotal (95% CI) 693 2079 100.0 % 0.30 [ 0.17, 0.54 ]
Total events: 12 (Task-shifting), 119 (Doctor care)
Heterogeneity: not applicable
Test for overall effect: Z = 3.99 (P = 0.000066)
Test for subgroup differences: Chi2 = 15.69, df = 1 (P = 0.00), I2 =94%
0.01 0.1 1 10 100
Favours task-shifting Favours doctor care
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Analysis 3.1. Comparison 3 Doctor versus community health worker, Outcome 1 Death (12 months).
Review: Task shifting from doctors to non-doctors for initiation and maintenance of antiretroviral therapy
Comparison: 3 Doctor versus community health worker
Outcome: 1 Death (12 months)
Study or subgroup
Community
worker care Doctor care Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Maintenance of ART in community (RCTs)
Jaffar 2009 (1) 36/330 25/229 100.0 % 1.00 [ 0.62, 1.62 ]
Subtotal (95% CI) 330 229 100.0 % 1.00 [ 0.62, 1.62 ]
Total events: 36 (Community worker care), 25 (Doctor care)
Heterogeneity: not applicable
Test for overall effect: Z = 0.00 (P = 1.0)
2 Maintenance of ART in community (Cohort)
Kipp 2010 24/185 18/200 100.0 % 1.44 [ 0.81, 2.57 ]
Subtotal (95% CI) 185 200 100.0 % 1.44 [ 0.81, 2.57 ]
Total events: 24 (Community worker care), 18 (Doctor care)
Heterogeneity: not applicable
Test for overall effect: Z = 1.24 (P = 0.21)
0.01 0.1 1 10 100
Favours community care Favours doctor care
(1) We have adjusted for clustering, making assumptions about the ICC (0.05) as it was not provided in the trial report.
55Task shifting from doctors to non-doctors for initiation and maintenance of antiretroviral therapy (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 3.2. Comparison 3 Doctor versus community health worker, Outcome 2 Lost to follow-up (12
months).
Review: Task shifting from doctors to non-doctors for initiation and maintenance of antiretroviral therapy
Comparison: 3 Doctor versus community health worker
Outcome: 2 Lost to follow-up (12 months)
Study or subgroup
Community
worker care Doctor care Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Maintenance of ART in community (RCTs)
Jaffar 2009 (1) 3/330 4/229 100.0 % 0.52 [ 0.12, 2.30 ]
Subtotal (95% CI) 330 229 100.0 % 0.52 [ 0.12, 2.30 ]
Total events: 3 (Community worker care), 4 (Doctor care)
Heterogeneity: not applicable
Test for overall effect: Z = 0.86 (P = 0.39)
2 Maintenance of ART in community (Cohorts)
Kipp 2010 22/185 16/200 100.0 % 1.49 [ 0.81, 2.74 ]
Subtotal (95% CI) 185 200 100.0 % 1.49 [ 0.81, 2.74 ]
Total events: 22 (Community worker care), 16 (Doctor care)
Heterogeneity: not applicable
Test for overall effect: Z = 1.27 (P = 0.20)
0.01 0.1 1 10 100
Favours community care Favours doctor care
(1) We have adjusted for clustering, making assumptions about the ICC (0.05) as it was not provided in the trial report.
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Analysis 3.3. Comparison 3 Doctor versus community health worker, Outcome 3 Death or lost to follow-up
(12 months).
Review: Task shifting from doctors to non-doctors for initiation and maintenance of antiretroviral therapy
Comparison: 3 Doctor versus community health worker
Outcome: 3 Death or lost to follow-up (12 months)
Study or subgroup
Community
worker care Doctor care Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Maintenance of ART in community (RCTs)
Jaffar 2009 (1) 39/330 29/229 100.0 % 0.93 [ 0.60, 1.46 ]
Subtotal (95% CI) 330 229 100.0 % 0.93 [ 0.60, 1.46 ]
Total events: 39 (Community worker care), 29 (Doctor care)
Heterogeneity: not applicable
Test for overall effect: Z = 0.30 (P = 0.76)
2 Maintenance of ART in community (Cohorts)
Kipp 2010 46/185 34/200 100.0 % 1.46 [ 0.98, 2.17 ]
Subtotal (95% CI) 185 200 100.0 % 1.46 [ 0.98, 2.17 ]
Total events: 46 (Community worker care), 34 (Doctor care)
Heterogeneity: not applicable
Test for overall effect: Z = 1.88 (P = 0.060)
Test for subgroup differences: Chi2 = 2.16, df = 1 (P = 0.14), I2 =54%
0.01 0.1 1 10 100
Favours community care Favours doctor care
(1) We assumed an ICC of 0.05 as none was provided in the trial report.
Analysis 3.4. Comparison 3 Doctor versus community health worker, Outcome 4 Cost to patient.
Cost to patient
Study Home based care Hospital based care
Jaffar 2009 total cost per year for transport, lunch, childcare costs, lost
work time: $18/year (after first year)
total cost per year for transport, lunch, childcare costs, lost
work time: $54/ year (after the first year)
Kipp 2010 Transport cost $0.74/ visit for home based care Transport cost $1.5/ visit for facility based care
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A D D I T I O N A L T A B L E S
Table 1. Framework: health service nomenclature in lower and middle-income countries
Tier Highest cadre Terms often used Facility and staff Equipment facilities
Community Individual with maxi-
mum of few months
training, paid or unpaid
Family led care Family member HIV tests, counselling,
replenish drugs
Community volunteer Trained volunteer;
health assistants
Primary care clinic Nurse aide or commu-
nity health workers
Health centre clinical officer or nurse
(2+ years training)
Health centres; district
hospitals
Purpose built with at
least one paramedic or
nurse with some health
assistants
HIV tests; antiretrovi-
rals; opportunistic infec-
tions medicines; point of
care laboratories
Health centre
(enhanced)
Clinical officer or nurse
(2 + years training)
Health centres, primary
health care clinics, dis-
trict hospitals
Purpose built with at
least one paramedic or
nurse with some health
assistants, with input
from a doctor (may be
via mobile support ser-
vice)
HIV tests; antiretrovi-
rals; opportunistic infec-
tions medicines; point of
care laboratories
Hospital Doctor Health centres; district
hospitals
Purpose built with at
least one medical doctor
with nurses / paramedics
and assistants
CD4 count
Medicines
Not viral load
Hospital (advanced) Specialist doctor District hospital; referral
hospital
Purpose built with at
least 2 specialist doctors
with nurses / paramedics
and assistants
Viral load and full inves-
tigations
Table 2. Description of Model of care in included studies
Model of care
Study ID Study design intervention control Co-interventions
Doctor versus nurse or clinical officer for initiation and maintenance of ART
Assefa 2011 Retrospective cohort Nurses and clinical of-
ficers initiate and main-
tain ART in health cen-
tres
Doctors initiate and
maintain ART in health
centres
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Table 2. Description of Model of care in included studies (Continued)
Bedelu 2007 Retrospective cohort Nurses and clinical of-
ficers initiate and main-
tain ART in health cen-
tre
Doctors initiate and
maintain ART in hospi-
tals
Fairall 2012
(Cohort 1)
Cluster randomised con-
trolled trial
Nurses ini-
tiate and maintain ART
(in health centres) in ad-
dition to training, as well
as educational and man-
agerial support
Doctors initiate and
maintain ART in health
centres
Model of care includes
specific training pack-
age, mentoring and su-
pervision and organisa-
tional changes to en-
sure support from clini-
cal managers
Sherr 2010 Retrospective cohort Clinical officers initiate
and maintain ART in
hospitals
Doc-
tor initiate and maintain
ART in hospitals
Doctor versus nurse or clinical officer for maintenance of ART
Fairall 2012
(Cohort 2)
Cluster randomised con-
trolled trial
Nurses follow up pa-
tients previously initi-
ated on ART by doctors,
for maintenance care of
ART in health centres
Doctors follow up pa-
tients who have previ-
ously been initiated on
ART by doctors for
ART maintenance care
in health centres
Model of care includes
specific training pack-
age, mentoring and su-
pervision and organisa-
tional changes to en-
sure support from clini-
cal managers
Humphreys 2010 Prospective cohort study Nurses follow up pa-
tients at the health centre
after initiation by doc-
tors at a hospital
Doctors follow up pa-
tients who have previ-
ously been initiated on
ART by doctors for ART
maintenance care in hos-
pitals
Matovu 2013 Randomised controlled
trial
Nurses follow up pa-
tients at the specialised
clinic at a hospital, with
support from peer coun-
sellors
Doctors follow up pa-
tients monthly at the
specialised clinic within
the hospital
Peer
counsellors do home vis-
its for patients who miss
appointments in the in-
tervention arm
Sanne 2010 Randomised controlled
trial
Nurses follow up pa-
tients already initiated
onARTby doctors at the
health centre
Doctors follow up pa-
tients who have previ-
ously been initiated on
ART by doctors for
ART maintenance care
in health centres
Intervention includes di-
dactic and clinical train-
ing, and there is avail-
able clinical supervision
as needed
Doctor versus community health worker for maintenance of ART
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Table 2. Description of Model of care in included studies (Continued)
Jaffar 2009 Cluster randomised con-
trolled trial
Field officers follow up
patients who had pre-
viously been initiated
by doctors on ART in
the community for ART
maintenance care
Doctors follow up pa-
tients who have previ-
ously been initiated on
ART by doctors for ART
maintenance care in hos-
pitals
Kipp 2010 Prospective cohort study Community volunteers
follow up patients previ-
ously initiated on ART
by clinical officers in
the community for ART
maintenance car
Doctors follow up pa-
tients who have previ-
ously been initiated on
ART by doctors for ART
maintenance care in hos-
pitals
A P P E N D I C E S
Appendix 1. MEDLINE Search strategy
Database: PubMed 1996 to 2014
Search Query
#7 Search #3 AND #4 AND #5 Limits: Publication Date from 1996/01/01 to 2013/03/25
#6 Search #3 AND #4 AND #5
#5 Search task* OR task-shifting OR referr* OR referral and consultation[mh] OR role*
#4 Search health personnel[mh]ORdoctorORdoctorsORclinicianORcliniciansORphysicianORphysiciansOR“healthcare
provider” OR “healthcare providers” OR “health care provider” OR “health care providers”
#3 Search #1 AND #2
#2 Search Antiretroviral Therapy, Highly Active[MeSH] OR Anti-Retroviral Agents[MeSH] OR Antiviral Agents[MeSH:
NoExp] OR ((anti) AND (hiv[tw])) OR antiretroviral*[tw] OR ((anti) AND (retroviral*[tw])) ORHAART[tw] OR ((anti)
AND (acquired immunodeficiency[tw])) OR ((anti) AND (acquired immuno-deficiency[tw])) OR ((anti) AND (acquired
immune-deficiency[tw])) OR ((anti) AND (acquired immun*) AND (deficiency[tw]))
#1 Search HIV Infections[MeSH] OR HIV[MeSH] OR hiv[tw] OR hiv-1*[tw] OR hiv-2*[tw] OR hiv1[tw] OR hiv2[tw]
OR hiv infect*[tw] OR human immunodeficiency virus[tw] OR human immunedeficiency virus[tw] OR human immuno-
deficiency virus[tw] OR human immune-deficiency virus[tw] OR ((human immun*) AND (deficiency virus[tw])) OR
acquired immunodeficiency syndrome[tw] OR acquired immunedeficiency syndrome[tw] OR acquired immuno-deficiency
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(Continued)
syndrome[tw] OR acquired immune-deficiency syndrome[tw] OR ((acquired immun*) AND (deficiency syndrome[tw]))
OR “sexually transmitted diseases, viral”[MESH:NoExp]
Appendix 2. CENTRAL search strategy
Database:CLIB(1996 - 2014)
ID Search
#1 MeSH descriptor HIV Infections explode all trees
#2 MeSH descriptor HIV explode all trees
#3 hiv OR hiv-1* OR hiv-2* OR hiv1 OR hiv2 OR HIV INFECT* OR HUMAN IMMUNODEFICIENCY VIRUS OR
HUMAN IMMUNEDEFICIENCY VIRUS OR HUMAN IMMUNE-DEFICIENCY VIRUS OR HUMAN
IMMUNO-DEFICIENCY VIRUS OR HUMAN IMMUN* DEFICIENCY VIRUS OR ACQUIRED
IMMUNODEFICIENCY SYNDROME OR ACQUIRED IMMUNEDEFICIENCY SYNDROME OR ACQUIRED
IMMUNO-DEFICIENCY SYNDROME OR ACQUIRED IMMUNE-DEFICIENCY SYNDROME OR ACQUIRED
IMMUN* DEFICIENCY SYNDROME
#4 MeSH descriptor Lymphoma, AIDS-Related, this term only
#5 MeSH descriptor Sexually Transmitted Diseases, Viral, this term only
#6 (#1 OR #2 OR #3 OR #4 OR #5)
#7 MeSH descriptor Antiretroviral Therapy, Highly Active, this term only
#8 MeSH descriptor Anti-HIV Agents explode all trees
#9 MeSH descriptor Antiviral Agents, this term only
#10 MeSH descriptor AIDS Vaccines, this term only
#11 ANTI HIV OR ANTIRETROVIRAL* OR ANTI RETROVIRAL* OR AIDS VACCIN*
#12 (#7 OR #8 OR #9 OR #10 OR #11)
#13 (#6 AND #12)
#14 MeSH descriptor Health Personnel explode all trees
#15 doctor* OR clinician* OR physician* OR “healthcare provider*” OR “health care provider*”
#16 (#14 OR #15)
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(Continued)
#17 MeSH descriptor Referral and Consultation explode all trees
#18 task* OR task-shifting OR referr* OR role*
#19 (#17 OR #18)
#20 (#13 AND #16 AND #19)
#21 (#13 AND #16 AND #19), from 1996 to 2013
Appendix 3. EMBASE search strategy
Database:EMBASE (1996 - 2014)
No. Query
#7 #3 AND #4 AND #5 AND [humans]/lim AND [embase]/lim AND [1996-2013]/py
#6 #3 AND #4 AND #5
#5 task* OR ’task-shifting’ OR referr* OR role* OR ’task performance’/syn OR ’patient referral’/syn
#4 ’health care personnel’/syn OR doctor* OR clinician* OR physician* OR ’healthcare provider’/syn OR ’healthcare providers’
OR ’health care provider’/syn OR ’health care providers’ OR ’health auxiliary’/syn
#3 #1 AND #2
#2 ’human immunodeficiency virus vaccine’/deOR ’human immunodeficiency virus vaccine’OR ’anti human immunedeficiency’:
ti OR ’anti human immunedeficiency’:ab OR ’anti human immunodeficiency’:ti OR ’anti human immunodeficiency’:ab OR
’anti human immuno-deficiency’:ti OR ’anti human immuno-deficiency’:ab OR ’anti human immune-deficiency’:ti OR ’anti
human immune-deficiency’:ab OR ’anti acquired immune-deficiency’:ti OR ’anti acquired immune-deficiency’:ab OR ’anti
acquired immunedeficiency’:ti OR ’anti acquired immunedeficiency’:ab OR ’anti acquired immunodeficiency’:ti OR ’anti
acquired immunodeficiency’:ab OR ’anti acquired immuno-deficiency’:ti OR ’anti acquired immuno-deficiency’:ab OR ’anti
hiv’:tiOR ’anti hiv’:abOR antiretrovir*:tiOR antiretrovir*:abOR ’anti retroviral’:tiOR ’anti retroviral’:abOR ’anti retrovirals’:
ti OR ’anti retrovirals’:ab OR ’anti retrovirus’:ti OR ’anti retrovirus’:ab OR haart:ti OR haart:ab OR ’aids vaccine’:ti OR ’aids
vaccine’:ab OR ’aids vaccines’:ti OR ’aids vaccines’:ab OR ’anti human immunodeficiency virus agent’/de OR ’anti human
immunodeficiency virus agent’ OR ’antiretrovirus agent’/de OR ’antiretrovirus agent’ OR ’antivirus agent’/de OR ’antivirus
agent’ OR ’highly active antiretroviral therapy’/de OR ’highly active antiretroviral therapy’
#1 ’human immunodeficiency virus infection’/exp OR ’human immunodeficiency virus infection’/de OR ’human immunode-
ficiency virus infection’ OR ’human immunodeficiency virus’/exp OR ’human immunodeficiency virus’/de OR ’human im-
munodeficiency virus’ OR ’b cell lymphoma’/de OR ’b cell lymphoma’ OR hiv:ti OR hiv:ab OR ’hiv-1’:ti OR ’hiv-1’:ab
OR ’hiv-2’:ti OR ’hiv-2’:ab OR ’human immunodeficiency virus’:ti OR ’human immunodeficiency virus’:ab OR ’human
immunedeficiency virus’:ti OR ’human immunedeficiency virus’:ab OR ’human immune-deficiency virus’:ti OR ’human im-
mune-deficiency virus’:ab OR ’human immuno-deficiency virus’:ti OR ’human immuno-deficiency virus’:ab OR ’acquired
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(Continued)
immunodeficiency syndrome’:ti OR ’acquired immunodeficiency syndrome’:ab OR ’acquired immuno-deficiency syndrome’:
ti OR ’acquired immuno-deficiency syndrome’:ab OR ’acquired immune-deficiency syndrome’:ti OR ’acquired immune-de-
ficiency syndrome’:ab OR ’acquired immunedeficiency syndrome’:ti OR ’acquired immunedeficiency syndrome’:ab
Appendix 4. Clinicaltrials.gov search strategy
Database: Clinicaltrials.gov (1996 - 2014)
Search strategy: HIV | doctor OR nurse OR physician OR “health personnel” OR “task shifting” OR referral | received from
01/01/1996 to 04/25/2013
Appendix 5. ICTRP search strategy
Database: ICTRP (1996 - 2014)
Search strategy: HIV | doctor% OR nurse% OR healthcare personnel OR physician% OR task& OR referral& OR role% |
received from 01/01/1996 to 04/25/2013
WH A T ’ S N E W
Last assessed as up-to-date: 28 March 2014.
Date Event Description
1 July 2014 Amended Correct affiliation.
H I S T O R Y
Protocol first published: Issue 3, 2008
Review first published: Issue 7, 2014
Date Event Description
8 June 2012 New citation required and major changes New authors taking forward this review
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C O N T R I B U T I O N S O F A U T H O R S
TK updated the protocol with the assistance of FBA, EP, MB.
All authors contributed to data extraction. TK and FBA undertook data entry and data analysis. TK and FBA conducted the GRADE
evaluation. TK wrote the first draft of the review, with the assistance of FBA. This was assessed by all authors prior to finalisation and
submission for peer review.
D E C L A R A T I O N S O F I N T E R E S T
We declare we have no affiliation with any organization or interest group that is involved in the topic of this review
S O U R C E S O F S U P P O R T
Internal sources
• South Africa Cochrane Centre HIV/AIDS Mentoring programme; Medical Research Council, South Africa.
External sources
• World Health Organization, Department of HIV/AIDS, Switzerland.
Provided part funding support towards completing this review, as a subcontract through the University of California, San Francisco
(UCSF)
• UKaid from the UK Government for the benefit of developing countries (DFiD), UK.
Funding received through a grant from DFiD to the Effective Health Care Research Consortium, Liverpool School of Tropical
Medicine
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We added attrition as an outcome, which is the composite of two of the outcomes: death and loss to follow-up. This was done as there
is published evidence that of those patients lost to follow-up in HIV programmes, approximately 40% may have died.
There were changes made to the original framework in the protocol describing the health service nomenclature for lower and middle
income settings. We added the concepts ’health centre (advanced)’ and ’hospital (advanced)’. Through our exploration of the trial and
programmatic reports it became clearer that in addition to services we had described, some of the facilities had additional assistance
from mobile or visiting doctors and specialists.
In the protocol, we planned to evaluated the risk of bias in included studies using the Newcastle - Ottawa approach, and EPOC criteria
for evaluating trials. We adapted these criteria to allow all components of the risk of bias to be displayed in the Cochrane Tool, although
specific criteria were adapted for the different included study designs.
In the protocol, we planned to conduct sensitivity analyses excluding trials with high risk of bias to evaluate the effects on the outcomes.
During the review process we identified anothermethodological challenge, which is the inclusion of both superiority and non-inferiority
study designs. We have amended our methods to include this possible sensitivity analysis of these trials in future reviews.
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I N D E X T E R M S
Medical Subject Headings (MeSH)
Africa; Anti-HIV Agents [∗therapeutic use]; Cohort Studies; Delegation, Professional [∗standards]; General Practice [standards]; HIV
Infections [∗drug therapy; mortality]; Health Services Accessibility [economics]; Induction Chemotherapy [standards]; Lost to Follow-
Up; Maintenance Chemotherapy [standards]; Practice Patterns, Nurses’ [∗standards]; Practice Patterns, Physicians’ [standards]; Ran-
domized Controlled Trials as Topic
MeSH check words
Humans
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